Tag: Health & Wellness Page 1 of 2

Not All Fat Is the Enemy

On June 23, 2026

A Plain-Language Guide to Dietary Fats, What They Do, and How to Make Better Choices

The Fat Myth That Stuck Around Too Long

For decades, the American food industry sold us a story: fat is bad, and less of it is better. By the 1980s and 1990s, supermarket shelves sagged under the weight of fat-free cookies, low-fat chips, and reduced-fat everything. The problem, of course, was that when food companies stripped out the fat, they often replaced it with sugar and refined carbohydrates to maintain flavor — and Americans got sicker anyway. Heart disease rates climbed. Obesity rates climbed. And gradually, the nutrition science world came to a more nuanced conclusion: what kind of fat you eat matters far more than how much.

Today, the scientific consensus is clear enough that even cautious institutions like the American Heart Association and Harvard’s School of Public Health distinguish sharply between fats that harm us and fats that we actually need to survive. This article walks through the main types of dietary fat — where they come from, what they do in the body, and how the average American can make smarter choices without turning every meal into a chemistry lesson.

The Chemistry, Simply Put

You don’t need a biochemistry degree to understand dietary fat, but a little structural context goes a long way. All fats are built from molecules called fatty acids — long chains of carbon atoms linked together, with hydrogen atoms attached. The difference between fat types comes down to how those hydrogen atoms are arranged.

Saturated Fats

Saturated fats are “saturated” with hydrogen atoms — meaning every carbon in the chain is bonded to as many hydrogens as it can possibly hold. This gives them a rigid, tightly packed structure. The practical consequence? Most saturated fats are solid at room temperature — think of the white fat marbled through a raw steak, or a stick of butter sitting on a counter.

Unsaturated Fats

Unsaturated fats have at least one double bond between carbon atoms in the chain — which means they are missing some hydrogen atoms. That double bond creates a “kink” in the molecular chain, preventing the fat molecules from packing tightly together. The result is that Unsaturated Fats

Unsaturated fats have at least one double bond between carbon atoms in the chain — which means they are missing some hydrogen atoms. That double bond creates a “kink” in the molecular chain, preventing the fat molecules from packing tightly together. The result is that unsaturated fats are liquid at room temperature, olive oil being the most familiar example.

Within unsaturated fats, there are two important subtypes based on how many double bonds exist. Monounsaturated fats (MUFAs) have exactly one double bond. Polyunsaturated fats (PUFAs) have two or more. Both behave very differently in the body than saturated fats and generally, much more favorably.

Trans Fats: The Artificial Villain

Trans fats deserve their own brief mention because they are the one type of fat that virtually every credible nutrition authority agrees should be avoided as completely as possible. Most trans fats are artificially created through a process called partial hydrogenation — taking liquid vegetable oil and pumping hydrogen through it under high pressure to make it solid and shelf-stable. The result is partially hydrogenated oil, which was found in margarine, shortening, packaged cookies, and countless processed snacks for most of the twentieth century.

The FDA banned the addition of partially hydrogenated oils to U.S. food products based on overwhelming evidence that industrial trans fats raise “bad” LDL cholesterol, lower “good” HDL cholesterol, and significantly increase cardiovascular risk. Small amounts of naturally occurring trans fats are found in animal products like beef and dairy, and these appear to be metabolically distinct from industrial trans fats — less concerning but still something most experts recommend limiting.

Saturated Fats in Detail

Where They Come From

Saturated fats are found predominantly in animal products and a handful of tropical plant oils. The major food sources include fatty cuts of beef and pork, poultry skin, full-fat dairy products (butter, whole milk, cream, cheese), lard, and beef tallow. On the plant side, coconut oil and palm oil are notably high in saturated fat — which surprises many people who assume all plant-based oils are heart-healthy. Coconut oil in particular has been heavily marketed as a “superfood” in recent years, a claim that runs in conflict with the science.

What They Do in the Body

The relationship between saturated fat and cardiovascular health has been one of the most debated topics in nutrition science for the past two decades. The original view, dominant for most of the 20th century, was straightforward: eating saturated fat raises LDL (“bad”) cholesterol, and higher LDL raises the risk of heart disease and type 2 diabetes. That basic chain of reasoning is still supported by substantial evidence.

However, the picture has grown more complicated. Research over the past decade has raised legitimate questions about whether all saturated fats are equally problematic, and whether saturated fat in isolation — rather than as part of an overall dietary pattern — is the right thing to be measuring. A study cited by the National Institutes of Health found that replacing saturated fats with refined carbohydrates (which is what happened when Americans went fat-free in the 1980s) did not reduce cardiovascular risk. The key variable isn’t just removing saturated fat — it was what you replace it with.

The evidence clearly shows that replacing saturated fats with unsaturated fats reduces cardiovascular risk. Replacing them with sugar and white flour does not. That distinction has become the cornerstone of modern dietary fat guidance.

How Much Is Too Much?

Current guidance varies slightly between major health organizations, but the general range is consistent. The Dietary Guidelines for Americans recommends keeping saturated fat below 10% of total daily calories. The American Heart Association is more conservative, recommending below 6% — which for a 2,000-calorie diet works out to about 13 grams per day, roughly the amount in a single tablespoon of butter combined with a small handful of cheese.

Monounsaturated Fats (MUFAs)

Where They Come From

Monounsaturated fats are the dominant fat in olive oil, avocados, peanut oil, canola oil, and most nuts — including almonds, cashews, and hazelnuts. They are the nutritional backbone of the Mediterranean diet, which has been studied more extensively for cardiovascular benefit than perhaps any other dietary pattern in history.

Health Benefits

The evidence in favor of MUFAs is robust . Monounsaturated fats lower LDL cholesterol while maintaining levels of HDL (“good”) cholesterol when they replace saturated fat in the diet. A clinical trial called the OmniHeart study found that shifting to a diet rich in monounsaturated fats — compared to a carbohydrate-rich diet — lowered blood pressure, improved cholesterol profiles, and reduced estimated cardiovascular risk. Beyond the heart, research suggests that swapping saturated fats for MUFAs may also support modest weight and body fat reduction even without changing total calorie intake.

MUFAs are also notably stable at cooking temperatures, which makes olive oil a practical and healthy choice for most everyday cooking — sautéing vegetables, making salad dressings, or roasting proteins.

Polyunsaturated Fats (PUFAs) — The Essential Fats

Polyunsaturated fats are, in many ways, the most scientifically interesting category because they include the only two dietary fats that the human body genuinely cannot produce on its own and must obtain from food. These are called essential fatty acids, and they fall into two families: omega-3s and omega-6s.

Omega-3 Fatty Acids

What They Are and Where They Come From

Omega-3s are the fats most Americans have heard of in the context of fish oil supplements. The three main types are ALA (alpha-linolenic acid), EPA (eicosapentaenoic acid), and DHA (docosahexaenoic acid). ALA is found primarily in plant sources — walnuts, flaxseeds, chia seeds, and canola or soybean oil. EPA and DHA are found in fatty fish — salmon, sardines, mackerel, herring, and trout — as well as in algae-based oils, which is where fish get their omega-3s in the first place.

The body can convert ALA into EPA and DHA, but only very inefficiently. For practical purposes, regular fish consumption is the most reliable way to maintain adequate EPA and DHA levels. The American Heart Association recommends at least two servings of fatty fish per week for this reason.

Health Benefits

Omega-3 fatty acids are structural components of cell membranes throughout the body and serve as precursors to signaling molecules that regulate inflammation. Their most well-established benefits are cardiovascular: they reduce triglyceride levels, stabilize heart rhythms, and appear to lower the risk of sudden cardiac death. Beyond the heart, research suggests they play important roles in brain development (particularly during fetal development and infancy), may reduce the risk of certain neurodegenerative conditions, and have documented anti-inflammatory effects relevant to conditions like rheumatoid arthritis.

A recent review published in the journal Foods found that omega-3s may help delay the onset of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease, reduce depression, and contribute to cancer prevention, though the authors note that more research is needed to fully understand these relationships.

Omega-6 Fatty Acids

What They Are and Where They Come From

Omega-6 fatty acids are found in most vegetable oils — corn oil, soybean oil, sunflower oil, safflower oil — as well as in nuts, seeds, and poultry. Linoleic acid (LA) is the primary dietary omega-6 and is the only one classified as truly essential.

The Omega-6/Omega-3 Imbalance

Here is where things get complicated in a uniquely American way. The typical Western diet contains far more omega-6 fats than necessary and not nearly enough omega-3 fats. The ideal ratio of omega-6 to omega-3 in the diet is thought to be somewhere between 4:1 and 1:1. The actual ratio in the average American diet is estimated at anywhere from 15:1 to 20:1 — a dramatic imbalance driven by the ubiquity of processed foods and vegetable oils in the food supply.

This matters because omega-6 and omega-3 fatty acids compete for the same metabolic pathways in the body. While omega-6s in appropriate amounts are essential and beneficial, a chronically elevated omega-6 to omega-3 ratio is associated with increased inflammation and higher risk of coronary heart disease, hypertension, diabetes, rheumatoid arthritis, and some neurodegenerative conditions. The goal is not to eliminate omega-6s but to bring the ratio back into better balance — primarily by increasing omega-3 intake.

What a Healthy Fat Profile Actually Looks Like

Putting all of this together, what does a well-balanced dietary fat intake actually look like? The evidence points toward a few consistent principles.

In a typical healthy diet, 20–35% of total daily calories can come from fat. Within that total, the composition matters enormously. Unsaturated fats — both mono and polyunsaturated — should make up the bulk. Saturated fats should be limited to under 10% of daily calories by federal guidelines, or under 6% if you are following the American Heart Association’s more aggressive recommendation. Trans fats, the industrial kind, should be avoided as close to completely as possible.

The two truly essential fats — linoleic acid (omega-6) and alpha-linolenic acid (omega-3) — must come from the diet because the human body cannot synthesize them. Everything else the body can manufacture from raw materials, given enough of the right building blocks.

For omega-3s specifically, the WHO and EFSA recommend at least 250 mg per day of EPA + DHA. And recommend 1.6 grams of ALA per day for adult males and 1.1 grams for adult females. Most Americans fall well short of these targets.

Practical Ways to Shift Your Fat Intake

Dietary change works best when it’s specific and sustainable — not when it involves a complete pantry overhaul overnight. Here are evidence-based adjustments that can meaningfully improve the fat profile of a typical American diet.

Replace Saturated Fats With Unsaturated Fats at the Cooking Stage

Instead of frying or sautéing in butter, lard, or palm oil, switch to olive oil, avocado oil, or canola oil. This single substitution is one of the most consistently supported interventions in dietary fat research. For those who prefer a buttery flavor, using a small amount of butter blended with olive oil is a practical middle ground.

Eat Fatty Fish Twice a Week

Salmon, sardines, mackerel, herring, and trout are all excellent sources of EPA and DHA omega-3s. The American Heart Association’s recommendation of two fish servings per week is a well-established and achievable benchmark. Canned fish — particularly canned salmon and sardines — is inexpensive and just as nutritious as fresh. Tuna is an option but requires an larger serving.

Add Nuts, Seeds, and Avocados

A handful of walnuts (a particularly good plant source of ALA omega-3s), a tablespoon of ground flaxseed in yogurt or oatmeal, or half an avocado on toast are all straightforward ways to shift your fat intake in a healthier direction. Nuts and avocados are also rich in monounsaturated fats that support cholesterol health.

Choose Leaner Cuts of Meat

Selecting leaner cuts of beef and pork — those labeled “loin” or “round,” or ground meat that is 90–95% lean — can substantially reduce saturated fat intake without eliminating meat from the diet. Removing skin from poultry before cooking similarly reduces saturated fat in a simple and inexpensive way.

Read Labels for Trans Fats — Carefully

Food packaging can legally claim “0 grams of trans fat” if a product contains less than 0.5 grams per serving. If you eat multiple servings of such products, those fractions add up. The safeguard is to check the ingredient list for “partially hydrogenated oil” — if it appears anywhere, the product contains industrial trans fats., regardless of what the front label says.

Limit — Don’t Necessarily Eliminate — Saturated Fat

A realistic goal is not to strip all saturated fat from your diet but to keep it within the recommended range. Full-fat dairy in moderate amounts, an occasional burger, or butter used sparingly are unlikely to cause harm in the context of an otherwise balanced eating pattern. What matters most, as nutrition experts now emphasize, is the overall dietary pattern — not any single food or nutrient in isolation.

The Bottom Line

Fat is not a dietary villain. It is an essential macronutrient that the body depends on for energy, vitamin absorption, hormone production, brain function, and cell membrane integrity. The question has never really been whether to eat fat — it has always been which fats to prioritize.

The evidence points consistently in one direction: lean toward unsaturated fats (olive oil, nuts, avocados, fatty fish), keep saturated fat in check, avoid industrial trans fats entirely, and pay particular attention to getting enough omega-3 fatty acids, which most Americans chronically under-consume. These adjustments don’t require extreme dietary measures. They require informed choices made consistently — and that, ultimately, is the most sustainable kind of nutrition science.

Illustration generated by author using ChatGPT

Note: The core findings in this article — that unsaturated fats are preferable to saturated fats, that omega-3 and omega-6 fatty acids are essential, and that industrial trans fats are harmful — are supported by decades of research and endorsed by major health authorities including the American Heart Association, the NIH, and the 2025 Dietary Guidelines Advisory Committee. Some nuance remains in the saturated fat debate (particularly regarding specific saturated fatty acid subtypes and their varying cardiovascular effects), and the research on omega-3s and neurological disease is still evolving.

Medical Disclaimer

The information provided in this article is intended for general educational and informational purposes only and does not constitute medical advice. It should not be used as a substitute for professional medical advice, diagnosis, or treatment.

Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read here.

If you are experiencing a medical emergency, call 911 or your local emergency number immediately.

The author of this article is a licensed physician, but the views expressed here are solely those of the author and do not represent the official position of any hospital, health system, or medical organization with which the author may be affiliated.

Sources

Dietary Guidelines Advisory Committee — Food Sources of Saturated Fat (2025)

Harvard T.H. Chan School of Public Health — Types of Fat

American Heart Association — Saturated Fats

American Heart Association — Fats in Foods

Mayo Clinic — Dietary Fat: Know Which to Choose

Mayo Clinic — Trans Fat Is Double Trouble for Heart Health

Healthline — Saturated vs. Unsaturated Fat: Know the Facts

Healthline — Omega-3–6–9 Fatty Acids: A Complete Overview

NCBI/PMC — Monounsaturated Fat vs Saturated Fat: Effects on Cardio-Metabolic Health and Obesity

NCBI/PMC — The Role of Omega-3 and Omega-6 Polyunsaturated Fatty Acid Supplementation in Human Health (Foods, 2025)

Linus Pauling Institute — Essential Fatty Acids

NIH — Omega-3 Fatty Acids Health Professional Fact Sheet

OCL Journal — The Omega-6/Omega-3 Fatty Acid Ratio: Health Implications

VA Nutrition Services — Common Fats and Oils (2024)

UMass Medical — Tips on Reducing Saturated Fat

MedlinePlus — Facts About Trans Fats

Brown University Health — The Truth About Trans Fats

University of Nebraska Extension — Omega-3 and Omega-6 Fatty Acids

When the Sun Bites Back

By John Turley

On June 3, 2026

In Medicine

A guide to sun injuries — what they are, how they happen, and how to protect yourself.

This is a long article; I recommend you scan through it and read the sections of most interest to you rather than trying to read through it in a single sitting.

The sun is arguably the most powerful force in our daily lives. It warms the planet, drives our seasons, and has shaped human biology for hundreds of thousands of years. A little sunlight genuinely is good for you — it triggers vitamin D production and helps regulate your sleep cycle. But the same energy that sustains life can also cause real, sometimes lasting harm when you get too much. We’re not just talking about a red nose after a day at the beach. Sun injuries span a wide spectrum, from the minor annoyance of a mild sunburn to life-threatening heat stroke to decades-long processes that end in skin cancer.

Let’s walk through the main categories of sun-related injury: what they are, the biology behind them, who’s most at risk, how to prevent them, and what to do when prevention comes too late.

The Sun’s Invisible Weapons: UV Radiation and Heat

Before we get into specific injuries, it helps to know what we’re dealing with. The sun delivers energy to Earth in three main forms: visible light (what you see), infrared radiation (what you feel as warmth), and ultraviolet (UV) radiation, which you can neither see nor feel. UV is the primary culprit behind most sun injuries to the skin and eyes.

UV radiation comes in three wavelength ranges. UVC is almost completely absorbed by the Earth’s atmosphere and generally doesn’t reach us from the sun. UVA and UVB are the ones that matter for your health. UVA rays make up the lion’s share of what reaches the Earth’s surface. They penetrate deep into the skin, cause aging effects, and suppress the immune system. UVB rays are shorter and more energetic — they’re the primary drivers of sunburn, and also the rays most directly linked to DNA damage and skin cancer. Surprisingly, even on a cloudy day a significant amount of UV radiation still reaches you.

Heat from the sun adds a second, separate threat. While UV damages cells at a molecular level, heat overwhelms the body’s ability to regulate its own temperature — a completely different mechanism leading to a different family of injuries.

The Types of Sun Injury

Sunburn

Sunburn is the most common sun injury, and most people have had at least one, some of us many more than one. It’s an acute inflammatory response triggered when UV radiation, primarily UVB, directly damages the DNA in skin cells. When that damage exceeds the ability of the cell’s repair machinery, the cell initiates a self-destruct process (called apoptosis) to prevent potentially cancerous mutations from propagating. The redness, pain, heat, and swelling of a sunburn are the skin’s inflammatory response to that mass cellular die-off.

Sunburn develops in a spectrum of severity. A mild burn produces redness and tenderness over exposed skin. A moderate burn adds blistering and significant pain. Severe sunburns are equivalent to a second-degree thermal burn and can involve extensive blistering, swelling, fever, chills, and nausea. In rare cases, especially in young children, severe sunburns can require hospitalization.

One thing worth knowing: even though we casually call sunburn a ‘first-degree burn,’ it’s technically not the same as a heat burn of the same grade. UV radiation penetrates to deeper layers of the skin than heat does, causing a different pattern of cellular injury.

Skin Cancer

This is where sunburn’s long tail becomes dangerous. Skin cancer is the most common cancer in the United States, with over 5 million cases diagnosed annually. The connection to UV exposure is not subtle — roughly 90 percent of non-melanoma skin cancers are directly associated with UV radiation from the sun.

There are three main types. Basal cell carcinoma (BCC) is the most common, with an estimated 3.6 million U.S. diagnoses each year. It tends to grow slowly and rarely spreads to other organs, but it can cause significant local destruction if ignored. Squamous cell carcinoma (SCC) is second in frequency, at about 1.8 million cases per year. It carries a somewhat higher risk of spreading than BCC. Melanoma is the least common but by far the most dangerous, accounting for most skin cancer deaths. It arises from the pigment-producing cells (melanocytes) and can spread rapidly to other organs.

The underlying mechanism in all three is UV-induced DNA damage. When UV radiation hits skin cells repeatedly over time, it scrambles the DNA segments that normally suppress tumor growth. Intermittent intense exposure — like a child getting several serious sunburns — appears particularly risky for melanoma. Cumulative lifetime exposure is more associated with BCC and SCC. Either way, the damage is slow and progressive and adds up invisibly for decades before a cancer appears.

Photokeratitis — Sunburn of the Eye

Most people have never heard of photokeratitis, but anyone who’s spent time on the water, in the snow, or at high altitude without sunglasses has been at risk. Photokeratitis is essentially a sunburn of the cornea, the clear front surface of the eye It is caused by intense or prolonged exposure to UVB radiation. It’s sometimes called ‘snow blindness’ in its most severe form, and ‘arc eye’ or ‘welder’s flash’ when caused by industrial UV sources.

At the cellular level, UV radiation interacts with cells in the cornea and conjunctiva (the membrane covering the eye), generating reactive oxygen species — unstable molecules that cause oxidative damage to cell membranes, proteins, and DNA. The inflammatory response that follows is what produces the characteristic symptoms: intense pain, a gritty sensation as though there’s sand in the eye, extreme sensitivity to light, tearing, and redness. These symptoms typically appear several hours after exposure, which is part of what makes photokeratitis so sneaky — you may not notice a problem until you’re back indoors for the evening.

The good news is that photokeratitis is almost always temporary. The cornea has a remarkable ability to regenerate its surface cells, and most cases resolve within 24 to 48 hours without any permanent damage to vision. Snow blindness occurs at high altitude where UV intensity is dramatically increased and fresh snow reflects up to 80 percent of incoming UV and is a more severe version that can temporarily blind a person, though new cells typically restore vision within a few days.

Long-term or repeated UV exposure to the eyes raises a different set of concerns. Cataracts, macular degeneration, and pterygium (a fleshy overgrowth on the eye surface) are all associated with lifetime cumulative UV exposure.

Heat-Related Illnesses

UV radiation isn’t the only player. The sun’s infrared energy — heat — creates a separate family of injuries when it overwhelms your body’s cooling mechanisms. These range from relatively mild to life-threatening.

Heat Cramps

Heat cramps are the mildest heat-related illness and present as painful muscle spasms that occur when you sweat heavily during strenuous activity in the heat. Sweating depletes both fluid and electrolytes (particularly sodium). They most often show up in the legs, arms, or abdomen. Treatment is straightforward: rest, move to a cooler spot, and slowly replace fluids and electrolytes.

Heat Exhaustion

Heat exhaustion is a more serious heat illness. It occurs when the body struggles to cool itself after prolonged heat exposure, often compounded by dehydration. Your core body temperature climbs, typically to between 100°F and 104°F. Symptoms include heavy sweating, headache, dizziness, nausea, rapid but weak pulse, and muscle cramps. The skin usually feels cool and moist. Without treatment, heat exhaustion can escalate into heat stroke.

Heat Stroke

Heat stroke is a medical emergency and the most severe heat illness. It occurs when the body’s temperature regulation fails entirely — the sweating mechanism breaks down, and the core body temperature can rise to 106°F or higher within 10 to 15 minutes. This is organ-threatening territory. Brain cells begin dying at sustained high temperatures, and heat stroke can cause permanent disability or death without rapid emergency treatment.

There are two clinical patterns. Classic heat stroke tends to affect the elderly, very young children, and people with chronic illness and occurs during prolonged heat waves. Exertional heat stroke hits otherwise healthy, physically active people — athletes, soldiers, outdoor workers — during intense physical activity in hot conditions. Both are emergencies, but exertional heat stroke can develop faster and with less warning.

Key warning signs that distinguish heat stroke from heat exhaustion: an extremely high body temperature (above 104°F), confusion or slurred speech, hot and dry skin (though not always), and loss of consciousness or seizures. If you suspect heat stroke, call 911immediately — this is not a wait-and-see situation.

Photosensitivity and Drug Reactions

A less-discussed but fairly common category of sun injury involves the interaction between UV radiation and certain medications or chemicals. Phototoxic reactions happen when a substance in or on the skin absorbs UV radiation and generates a chemical reaction that damages tissue — essentially a chemical sunburn. Photoallergic reactions are immune-mediated: the UV-altered substance triggers an immune response, producing a rash that can spread even to sun-unexposed areas.

Medications commonly associated with photosensitivity include certain antibiotics (especially tetracyclines and fluoroquinolones, cipro being the most common), diuretics, some blood pressure medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and some antidepressants. If you’ve started a new medication and notice unusual sun sensitivity, it’s worth having a conversation with your prescriber.

Who’s Most Vulnerable?

While the sun doesn’t discriminate, some people are more vulnerable to sun injury than others.

Skin tone matters enormously for UV-related injury. People with lighter skin have less melanin — the pigment that absorbs UV and dissipates it as heat, protecting underlying cells. Fair-skinned people sunburn faster and face a higher lifetime risk of skin cancer. That said, darker-skinned individuals are absolutely not immune: skin cancers in Black, Asian, and Hispanic patients tend to be diagnosed at later, more dangerous stages, partly because they’re less expected. Melanoma in particular has a much lower five-year survival rate in Black patients (around 70 percent) compared to white patients (around 95 percent).

Children deserve special attention. Their developing skin and eyes are more sensitive to UV damage, and the evidence is strong that severe sunburns during childhood and adolescence significantly increase the lifetime risk of melanoma. Generally, a disproportionate amount of a person’s lifetime UV exposure is accumulated before age 18.

For heat illness, the calculus shifts. The elderly and very young children are most vulnerable because their thermoregulatory systems are less efficient. People with chronic illnesses such as heart disease, kidney disease, diabetes, obesity, face elevated risk. So do people taking medications that interfere with sweating or fluid balance. Outdoor workers and athletes are at occupational risk, particularly when they haven’t had time to acclimatize to heat.

Prevention: The Real Work Happens Before You Go Outside

Sunscreen — But Use It Right

The evidence that sunscreen prevents skin cancer is solid overall, though the picture is more nuanced than the marketing suggests. High-quality evidence shows that regular daily use of a broad-spectrum SPF 15 sunscreen reduces the risk of developing squamous cell carcinoma by about 40 percent and reduces melanoma risk by roughly 50 percent. The catch is application. Under real-world conditions, people typically apply far less sunscreen than the amount used in lab testing which can cut the effective SPF roughly in half. Sunscreen also needs to be reapplied every two hours and after swimming or heavy sweating; most people don’t do this.

The American Academy of Dermatology recommends a broad-spectrum sunscreen (meaning it covers both UVA and UVB) with an SPF of at least 30 for everyday use, and SPF 50 for extended outdoor activity. ‘Broad spectrum’ is key — pure UVB filters leave you unprotected from UVA, which drives skin aging and contributes to skin cancer.

On the regulatory front, there’s encouraging news. In late 2025, Congress passed the SAFE Sunscreen Standards Act, which allows the FDA to accept safety data from other countries when evaluating new sunscreen ingredients. The U.S. has long lagged behind Europe and Asia in available sunscreen chemistry, so this could eventually broaden consumer options significantly.

Clothing and Shade

Arguably the most underrated sun protection strategy is also the simplest: cover up and get out of direct sun. Tightly-woven, loose-fitting clothing provides a meaningful physical barrier to UV. Clothing with a labeled UPF (ultraviolet protection factor) rating offers quantified protection. A wide-brimmed hat protects the face, ears, and neck — areas that accumulate a lot of UV exposure and are common sites for skin cancer.

Seek shade during peak UV hours, which run from about 10 a.m. to 4 p.m. Keep in mind that trees, umbrellas, and canopies reduce but don’t eliminate UV exposure — surfaces like sand, water, and snow reflect UV back at you from below, partially defeating the shade above you.

Eye Protection

Sunglasses that block 99 to 100 percent of UVA and UVB are very important and are not just a fashion accessory. Wraparound styles provide better coverage than narrow frames, since UV can reach the eye from the sides. For winter sports or high-altitude activities, glacier glasses or goggles with side shields are the appropriate choice — fresh snow can reflect up to 80 percent of UV radiation, and the UV intensity at altitude is substantially higher than at sea level.

Managing Heat Risk

Preventing heat illness comes down to a few fundamentals: stay hydrated before and during outdoor activity and don’t neglect to continue to hydrate after you have finished. Schedule strenuous work or exercise in the early morning or evening, wear lightweight and light-colored clothing, take breaks in shaded or air-conditioned spaces. Be sure to allow your body time to acclimatize when moving to a hotter climate — and that includes vacations.

Hydration specifics matter. The general guidance for outdoor exercise is to drink about 24 ounces of fluid two hours before activity, and about 8 ounces every 20 minutes during exertion — even if you don’t feel thirsty. When I was in the Marines and serving in a tropical environment, we were advised to “drink until you slosh”. In extreme heat, an electrolyte-containing sports drink can be more appropriate than plain water, since heavy sweating depletes sodium and other minerals that plain water doesn’t replace.

Never leave children, the elderly, or pets in a parked car on a warm day. Car interiors can reach dangerous temperatures remarkably quickly, and dark dashboards and seats can hit temperatures above 180°F.

Treatment: When the Sun Has Already Won

Treating Sunburn

There is no treatment that reverses UV damage once it’s occurred, so sunburn management is fundamentally about reducing inflammation and discomfort while the skin heals. Cool (not ice cold) baths or compresses help with pain and inflammation. Over-the-counter NSAIDs like ibuprofen or aspirin reduce inflammation systemically. Aloe vera gel and fragrance-free moisturizers help with the dryness and peeling that follow. Hydration is important, since burned skin loses water faster than intact skin.

Avoid applying petroleum jelly, butter, or any product that traps heat in the skin — these are folk remedies that can worsen the burn. Avoid further sun exposure until the burn has healed. Blistered burns should be left intact; breaking blisters increases infection risk. A severely blistered sunburn, or one accompanied by high fever, severe pain, confusion, or extensive skin involvement, warrants medical attention.

Treating Photokeratitis

Eye sunburn is treated with rest, darkness, and time. Remove contact lenses immediately. Cool compresses over closed eyes can ease the pain. Over-the-counter lubricating eye drops help with the irritation, and oral pain relievers can help with the deeper ache. Avoid rubbing the eyes. Most cases resolve within 24 to 48 hours. If pain or vision disturbance persists beyond 48 hours, or if vision changes occur, see an eye care professional promptly.

Treating Heat Exhaustion

Act quickly. Move the person to a cool or shaded area, loosen or remove excess clothing, and have them lie down with legs slightly elevated to improve circulation. Use any available means to cool the body: wet towels, fans, cool mist. Slowly give cool water or a sports drink. Call for medical assistance, since heat exhaustion can tip into heat stroke without warning.

Treating Heat Stroke

Heat stroke is a 911 emergency. While waiting for emergency services, move the person to a cool environment, remove outer clothing, and cool them by any means available — cool water applied to the skin, fanning, ice packs to the groin and armpits (where large blood vessels run close to the surface). Crucially: do NOT give fluids to someone who may have heat stroke, since confusion or impaired consciousness creates a choking risk. Hospital treatment typically involves intravenous fluids and active cooling measures. Every minute of delay increases the risk of permanent brain damage or death.

Long-Term Management: Skin Cancer

Skin cancer detected early is highly treatable. The American Academy of Dermatology recommends annual skin checks by a dermatologist for adults with significant sun exposure history, a personal or family history of skin cancer, or a large number of moles. Know the ABCDE warning signs: Asymmetry, irregular Border, uneven Color (especially multiple colors in one lesion), Diameter greater than a pencil eraser, and Evolution (any change in size, shape, or color over time). A new growth or a sore that doesn’t heal also warrants prompt evaluation.

A Final Thought

The sun isn’t going anywhere, and we wouldn’t want it to. But the injuries it causes — from the trivial to the fatal — are almost entirely preventable with a combination of awareness and habit. The frustrating reality is that the damage we’re preventing today won’t make itself known for years or decades. Nobody feels their melanoma forming at 35 or while they’re sitting on the beach at 22. That temporal gap is why sun safety behaviors are so psychologically difficult to maintain — the consequences feel abstract right up until they’re not.

The good news is that sunscreen, shade, adequate hydration, and protective clothing are not especially burdensome interventions. The return on that modest investment, measured in avoided skin cancers, avoided heat emergencies, and preserved eyesight, is substantial. Your future self will thank your present self for making it a habit.

Image generated by author using ChatGPT

Sources

Sunburn pathophysiology — PMC / ePlasty (2024) — https://pmc.ncbi.nlm.nih.gov/articles/PMC11374383/

UV radiation and human health — WHO Q&A — https://www.who.int/news-room/questions-and-answers/item/radiation-the-known-health-effects-of-ultraviolet-radiation

UV radiation and health effects — UNDRR — https://www.undrr.org/understanding-disaster-risk/terminology/hips/et0202

UV radiation and sun exposure — U.S. EPA — https://www.epa.gov/radtown/ultraviolet-uv-radiation-and-sun-exposure

Photokeratitis: causes, symptoms, treatment — All About Vision — https://www.allaboutvision.com/conditions/keratitis/photokeratitis/

Heat exhaustion — Cleveland Clinic — https://my.clevelandclinic.org/health/diseases/21480-heat-exhaustion

Heat stroke symptoms and treatment — WebMD — https://www.webmd.com/a-to-z-guides/heat-stroke-symptoms-and-treatment

Heat-related illnesses — CDC/NIOSH — https://www.cdc.gov/niosh/heat-stress/about/illnesses.html

Dehydration and heat stroke — Johns Hopkins Medicine — https://www.hopkinsmedicine.org/health/conditions-and-diseases/dehydration-and-heat-stroke

Heat illness — NOAA — https://www.noaa.gov/stories/heat-exhaustion-or-heat-stroke-know-signs-of-heat-illness

Skin cancer facts and statistics — Skin Cancer Foundation — https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/

Skin cancer statistics — American Academy of Dermatology — https://www.aad.org/media/stats-skin-cancer

Sunscreen efficacy and skin cancer prevention — CMAJ (2020) — https://www.cmaj.ca/content/192/50/E1802

Modernizing U.S. sunscreen regulations — PMC (2025) — https://pmc.ncbi.nlm.nih.gov/articles/PMC12332967/

New sunscreen laws — Health Central (2026) — https://www.healthcentral.com/condition/skin-cancer/new-sunscreen-formulas-are-on-the-way

Sunscreen and melanoma risk — ASCO Journal of Clinical Oncology — https://ascopubs.org/doi/10.1200/JCO.2016.69.5874

Medical Disclaimer

If you are experiencing a medical emergency, call 911 or your local emergency number immediately.

The Gummy Revolution: Sweet Convenience or Health Trade-Off?

By John Turley

On May 22, 2026

In Medicine

A plain-language look at gummy vitamins and medications — the good, the bad, and the sticky

Not Your Grandma’s Vitamin

Walk down the supplement aisle of any pharmacy or big-box store and you’ll find row after row of brightly colored bottles filled with gummy bears, worms, and rings that smell vaguely of fruit punch. Decades ago, vitamins came in white tablets that tasted like chalk and left you feeling vaguely like you’d swallowed a piece of sidewalk. Today, a not-insignificant share of the American supplement market looks and tastes a whole lot like candy. That shift didn’t happen by accident, and understanding what’s driving it — and what it costs — is worth your time.

Gummy formulations now cover everything from vitamin C and melatonin to prenatal multivitamins and, increasingly, actual prescription-adjacent medications. The format has clear appeal, especially for children who resist pills and adults who find swallowing large tablets unpleasant or outright difficult. But behind that chewy exterior lies a more complicated picture involving sugar, unreliable dosing, dental damage, and real safety risks that most consumers never think about.

The Appeal Is Real

Let’s give credit where it’s due: the biggest genuine advantage of gummy vitamins isn’t nutritional — it’s behavioral. According to University Hospitals, the primary benefit of gummies over traditional supplements is people will take them more consistently. A vitamin sitting in your cabinet because you hate the taste is worthless. A gummy you look forward to, however modest its nutritional profile, at least does something. That’s not a trivial point.

For parents of young children, this is often a decisive factor. Getting a five-year-old to swallow a pill can feel like an Olympic sport. Gummies sidestep the fight entirely. And for elderly patients managing complex medication regimens, or anyone with a swallowing disorder (called dysphagia), gummies and chewables offer a useful alternative to pills and capsules.

There’s also a psychological dimension. Taking a gummy feels like a small reward rather than a medical obligation, and that association can make adherence to a supplement routine more sustainable. That may sound trivial, but in the real world of patient behavior, it matters.

Gummies may be gentler on the stomach than some traditional tablets because they lack certain binding agents and can sometimes be taken without food or large volumes of water, reducing nausea for sensitive users.

The popularity of gummy medications reflects a broader shift in medicine toward consumer-friendly products. Yet the fact that a medication tastes like candy does not make it harmless.

What’s in the Gummy?

Here’s where things start to get complicated. A standard gummy vitamin isn’t just vitamins. Its base is a blend of gelatin or pectin, corn starch, water, and — almost always — sugar or some form of sweetener. UCLA Health reports that most gummy vitamins contain between 2 and 8 grams of sugar per serving. The American Heart Association recommends no more than 25 grams of added sugar per day for women and 36 grams for men. That is a meaningful slice of a daily sugar budget, especially for someone taking multiple gummies.

The presence of all those filler ingredients — coloring, flavoring, gelling agents — creates a real-world engineering problem for manufacturers: there’s only so much space in a gummy bear. That means there is less room for actual vitamins and minerals.

Many gummy multivitamins leave out key minerals such as iron or zinc, or include them only in small amounts, because certain minerals affect taste or texture or are harder to formulate in a palatable gummy. As a result, relying solely on gummies may leave gaps compared with a well‑formulated tablet or capsule. As Cleveland Clinic notes, gummy vitamins typically contain fewer vitamins and minerals than regular vitamins, and it can be difficult to determine exactly how much nutrition you’re getting.

Sugar-free versions aren’t automatically off the hook either. Many use sugar alcohols like sorbitol or maltitol, which can cause bloating, gas, and diarrhea when consumed in any significant quantity. Others rely on high-sugar fruit juice concentrates that, while technically “no added sugar,” still deliver a meaningful glycemic hit.

The Sugar Problem — Beyond Calories

Your Teeth Are Paying the Price

The sugar content of gummy vitamins isn’t just a caloric issue — it’s a dental one, and it may be more damaging than eating equivalent sugar in another form. The reason comes down to the gelatin matrix. Dental researchers at Tufts University School of Dental Medicine explain that gummies carry roughly the same cavity risk as candy because sticky substances with sugar create oral health problems by lingering against tooth enamel far longer than liquids or even hard candies do.

When you eat ordinary sugary food, your saliva, tongue, and cheeks gradually help clear it away. Gelatin disrupts that process. It’s adhesive by design, that’s what makes gummies chewy rather than crumbly and it holds sugar against tooth surfaces far longer than normal. Bacteria in the mouth metabolize sugar and produce acids, which attack enamel in a process called demineralization. The result: an elevated risk of cavities that many never see coming because they’re thinking of these as health products, not candy.

Most gummy vitamins also contain citric acid, added for flavor. Citric acid softens enamel directly, creating a one-two punch: first the acid weakens the enamel, then the bacteria exploit the weakened surface. Brushing too soon after eating gummies can make things worse, since brushing acid-softened enamel can mechanically remove tooth structure. Dentists recommend rinsing with water immediately after chewing a gummy and waiting at least 30 minutes before brushing.

This is not a hypothetical concern. Pediatric dentists report seeing increased cavity rates in children whose parents switched to gummy vitamins as a supposedly healthier treat alternative. The irony — giving a child a health supplement that damages their teeth — is both real and under appreciated.

Diabetics, Diabetic-Adjacent, and Anyone Watching Sugar

For patients managing type 2 diabetes, pre-diabetes, metabolic syndrome, or insulin resistance, the sugar content of gummy vitamins isn’t just a dental annoyance — it’s a medication management issue. Taking multiple gummies daily, across different supplement categories (vitamin D, omega-3, calcium, melatonin, a multivitamin), can add up to a meaningful daily sugar load that was never accounted for in a dietary plan. Most people don’t track gummy sugar content the way they track the sugar in a soda, but they should.

The Dosing Problem Is Bigger Than You Think

What the Label Says vs What’s in the Bottle

Here’s a fact that should give anyone pause: gummy vitamins have a shorter shelf life than traditional pills and tablets, and the vitamins inside them degrade over time. To compensate, manufacturers sometimes overfill gummies at the time of production, meaning a freshly manufactured product may contain significantly more of a given vitamin than the label states, while an older product approaching its expiration date may contain considerably less.

The label on a gummy vitamin is, at best, a rough approximation. You might be getting 150% of what’s stated, or 60% of what’s stated, depending on when the product was manufactured and how long it sat on the shelf or in your cabinet. For most vitamins, this imprecision is inconvenient but not dangerous. For fat-soluble vitamins — specifically A, D, E, and K — it can become a genuine safety concern.

Unlike water-soluble vitamins such as C or the B vitamins, fat-soluble vitamins accumulate in the body’s fat tissue and liver rather than being excreted in urine. Consuming significantly more than your body needs over time can lead to toxicity. Vitamin A toxicity (hypervitaminosis A) can cause liver damage, bone loss, and a range of neurological symptoms. Vitamin D toxicity, while less common, can cause dangerously elevated calcium levels. The gummy format’s inherent dosing imprecision is most concerning precisely for the vitamins where precision matters most.

The Candy Problem and Accidental Overdose

Gummy vitamins taste like candy. They look like candy. Children cannot reliably distinguish them from candy, and the packaging is often designed with cartoon characters and bright colors that actively appeal to children. The predictable result: accidental ingestion. Poison control centers in the U.S. receive reports of over 60,000 vitamin toxicity events every year, and children under six account for the majority of those.

The FDA has taken notice. In late 2023, the agency convened a meeting of experts specifically to discuss the risks of candy-like nonprescription drug products, including gummy vitamins and OTC sleep aids. Among the concerns raised: packaging that uses cartoon characters and gummy worm shapes that blur the line between supplement and treat. Historically, a documented 500% spike in pediatric overdoses occurred in the late 1940s and early 1950s when drug companies began marketing kid-friendly aspirin and that was a less appealing format than gummies. History, it seems, may be repeating.

For households with young children, the safety implication is straightforward: gummy vitamins — regardless of how benign they may seem — should be stored exactly as any medication would be, in child-resistant containers and out of reach. The pleasant taste is precisely what makes them dangerous when a toddler finds them.

Regulatory Gaps and Quality Control

Supplements Aren’t Drugs

Let’s be clear about the regulatory landscape, because it matters more than most people realize. The FDA classifies dietary supplements — including gummy vitamins — as food items, not drugs. That means manufacturers don’t have to demonstrate safety and efficacy before bringing a product to market the way pharmaceutical companies do. The burden of proof is essentially reversed: the FDA must demonstrate that a product is unsafe before it can be pulled from shelves.

The practical consequences are significant. A gummy vitamin that claims to support immune health doesn’t have to prove that it does. A study analyzing supplements marketed for brain health and cognitive performance found that 83% contained compounds not listed on the label. Some contained prescription drug compounds. Heavy metals including lead, arsenic, cadmium, and mercury have been detected in dietary supplement products. Third-party testing exists (look for seals from NSF International, USP, or ConsumerLab), but it’s voluntary, and most products on the market haven’t been independently verified.

This isn’t an argument against supplements across the board — it’s an argument for educated consumption. If you or your physician have identified a specific nutritional deficiency, a targeted, independently verified supplement in a traditional tablet or capsule form will almost always deliver more reliable dosing than its gummy equivalent.

What about Prescription Gummies?

A growing number of prescription medications are being formulated as gummies or gummy-like chewables. The pharmaceutical industry sees significant potential in these products for pediatric and geriatric populations. However, prescription medications introduce additional challenges because many drugs require extremely precise dosing and predictable absorption characteristics. Compounded prescription gummies prepared by specialty pharmacies are already being marketed for conditions such as erectile dysfunction, sleep disorders, hormonal therapy, and hair loss. These require very specific prescriptions and many of these are not FDA-approved as finished pharmaceutical products, even though the active ingredients themselves may be FDA-approved.

Consumers should be cautious about products marketed online as “prescription gummies,” especially for weight loss, sexual enhancement, bodybuilding, or “natural” performance enhancement. The FDA has found hidden prescription drugs inside some supposedly “herbal” gummies. Several products sold as sexual-enhancement gummies were found to contain non- documented tadalafil, the active ingredient in Cialis. This can be dangerous, especially in patients taking nitrates or cardiac medications.

A Balanced Bottom Line

Gummy vitamins occupy a genuine and useful niche. For children who won’t take pills, for adults with swallowing difficulties, for patients who simply need a behavioral nudge to take something they’d otherwise skip — the gummy format serves a real purpose. Compliance is a legitimate medical outcome, and if the gummy gets someone to take their vitamin D consistently when they otherwise wouldn’t, that has value.

But gummies should be approached with clear eyes. They contain sugar — often more than people realize — and that sugar can damage teeth, complicate blood sugar management, and add up when multiple supplements are taken daily. Their dosing is inherently less precise than traditional formulations, a problem that grows more serious with fat-soluble vitamins that can accumulate to toxic levels. They pose a real accidental overdose risk in homes with children. And they exist in a regulatory environment that places the burden of quality assurance squarely on the consumer.

If you’re going to use gummies, the practical advice is consistent across medical sources: choose brands that have been independently third-party tested, keep them locked away from children, rinse your mouth with water after taking them, don’t substitute them for a meaningful medical intervention without your doctor’s input, and be especially cautious with fat-soluble vitamin gummies where dosing precision matters most. And if you’re taking them alongside prescription medications, tell your doctor — interactions and supplement contamination are real, if underappreciated, risks.

The gummy revolution isn’t going anywhere. The market is too large and the convenience too appealing. But the best version of that revolution is one where consumers understand what they’re actually putting in their mouths.

Image generated by author using ChatGPT.

Sources

1. WebMD — Gummy Vitamins: What to Know. https://www.webmd.com/vitamins-and-supplements/what-to-know-about-gummy-vitamins

2. UCLA Health — Should You Take Gummy Vitamins? https://www.uclahealth.org/news/article/should-you-take-gummy-vitamins

3. University Hospitals — Are Gummy Vitamins as Good as the Real Thing? https://www.uhhospitals.org/blog/articles/2026/01/are-gummy-vitamins-as-good-as-the-real-thing

4. Cleveland Clinic — Do Gummy Vitamins Work as Well as Traditional Vitamins? https://health.clevelandclinic.org/do-gummy-vitamins-work-as-well-as-traditional-vitamins

5. Ochsner Health — Are Gummy Vitamins Effective or Just a Sweet Treat? https://blog.ochsner.org/articles/are-gummy-vitamins-healthy/

6. Scripps Health — Do Gummy Vitamins Really Work? https://www.scripps.org/news_items/7270-do-gummy-vitamins-really-work

7. Healthline — Are Gummy Vitamins Good or Bad? https://www.healthline.com/nutrition/gummy-vitamins

8. MedShadow Foundation — Dangers of Gummy, Patch, and Powder Vitamin Supplements. https://medshadow.org/integrative-health/non-drug-supplements/dangers-of-gummy-patch-and-powder-vitamin-supplements/

9. STAT News — The FDA Weighs the Risks of Candy-Like Nonprescription Drugs. https://www.statnews.com/2023/10/30/candy-like-drugs-gummies-fda-halloween-eve/

10. FDA — Dietary Supplements: Questions and Answers. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements

11. Tufts University School of Dental Medicine — Something to Chew On Before You Sink Your Teeth into Those Gummy Vitamins. https://now.tufts.edu/2024/07/25/something-chew-you-sink-your-teeth-those-gummy-vitamins

12. SingleCare — What Happens If You Eat Too Many Gummy Vitamins? https://www.singlecare.com/blog/too-many-gummy-vitamins/

13. GoodRx — Can You Overdose on Vitamins? https://www.goodrx.com/well-being/supplements-herbs/overdose-on-vitamins

Medical Disclaimer

If you are experiencing a medical emergency, call 911 or your local emergency number immediately.

Keeping Things Moving: Bowel Health for Seniors

By John Turley

On May 11, 2026

In Medicine

Introduction

Let’s talk about something that affects nearly a third of all older adults but rarely makes it into polite dinner conversation: bowel movements. Specifically, how often should you be having them, what happens when you don’t, and what can you do about it. This isn’t exactly cocktail party material, but it matters, a lot, for your comfort, your health, and your overall quality of life.

Constipation is extraordinarily common in people over 60. Some estimates put the rate of chronic constipation as high as 30% in community-dwelling older adults, and it climbs up to 50% among nursing home residents. Yet it remains under-discussed, under-treated, and frequently dismissed as just a normal part of getting older. Spoiler alert: it isn’t.

What Is a “Normal” Bowel Movement Schedule for Seniors?

Here’s a liberating fact: there is no single right answer to how often you should go. The notion that everyone should have a bowel movement every day is a myth. The accepted medical range for normal stool frequency is anywhere from three times a day to three times a week. If you’re comfortable, there’s no straining, and nothing has dramatically changed from your usual pattern, you’re probably fine.

For most seniors, having a bowel movement once a day to three times a week falls within the typical range. The key phrase here is “typical for you.” What matters clinically is consistency and comfort, not hitting some magic daily number.

A large National Health Interview Survey of over 42,000 participants found something that surprises many people: infrequent bowel movements don’t automatically increase with age the way conventional wisdom has long assumed. As the researchers noted in the Annals of Internal Medicine, a decline in bowel movement frequency is “not an invariable concomitant of aging.”

So what does change with age? The colon can slow its transit time — the speed at which food waste travels from one end to the other. Muscle tone in the abdomen and pelvic floor may decrease. Nerve sensitivity in the rectum can diminish, meaning you may not feel the urge to go as acutely as you once did. Add reduced physical activity, inadequate fluid intake, and a roster of medications, and you have a recipe for sluggishness down below.

Harvard Health recommends paying attention to any dramatic departure from what’s normal for you. If you typically go once a day and suddenly you’re going once a week without an obvious explanation like a change in diet or travel, that’s worth discussing with your doctor. Especially if it comes with fatigue, pain, unintentional weight loss, blood in the stool, or a change in consistency.

The Downside of Infrequent Bowel Movements

Constipation might seem like just an inconvenience, but when it becomes chronic or severe, the consequences can be surprisingly serious. Here’s a rundown of what can go wrong.

Fecal Impaction

The most dangerous complication of untreated chronic constipation is fecal impaction — when hardened stool becomes lodged in the colon or rectum and simply cannot pass. This is a genuine medical emergency. In the UK, fecal impaction has been identified in about 40% of hospitalized older patients. What makes it particularly tricky is that it can masquerade as diarrhea: liquid stool from above the blockage leaks around the impaction, creating what’s called overflow incontinence. If left untreated, impaction can cause intestinal obstruction, ulceration of the bowel wall, and even perforation and these can be life-threatening.

Hemorrhoids and Anal Fissures

Chronic straining on the toilet puts enormous pressure on the veins around the rectum, which can produce hemorrhoids — swollen, painful, and sometimes bleeding. Hard stools can also cause small tears called anal fissures, which are painful and can bleed with each bowel movement. These aren’t just uncomfortable; they can signal that something needs to change.

Quality of Life

Don’t underestimate how much chronic constipation chips away at daily life. Studies using validated quality-of-life instruments have consistently found that constipated older adults score lower on measures of physical functioning, mental health, general health perception, and management of bodily pain. Some studies even found improvements in mood and depression once constipation was successfully treated. This is not a trivial problem.

Confusion and Cognitive Effects

In older adults, particularly those with dementia, unresolved constipation can contribute to confusion, agitation, and behavioral changes. Clinicians who work in geriatrics are trained to consider constipation when an older patient with cognitive impairment suddenly becomes more agitated or confused. It’s one of those connections that surprises non-clinicians but is well recognized in eldercare.

A Note on Red Flags

It bears repeating, new, unexplained constipation, especially in an older adult who hasn’t had it before, deserves medical evaluation. Colon cancer, among other serious conditions, can present as a change in bowel habits. Blood in the stool, unexplained weight loss, iron-deficiency anemia, or a family history of colorectal cancer are all signals to see your doctor promptly rather than reaching for a laxative.

Non-Pharmacological Approaches

Good news: there’s a lot you can do before opening the medicine cabinet. Lifestyle measures are always considered first-line therapy, and for many people, they’re enough.

Fiber Intake

Dietary fiber is the single most important nutritional factor in maintaining regular bowel movements. Fiber adds bulk to stool and helps it move through the colon more efficiently. Whole grains, fresh fruits, vegetables, legumes, dried fruits like prunes, figs, and apricots are all solid choices. Prune juice, in particular, contains sorbitol, a natural sugar that acts as a mild laxative (but I have to admit, it’s not my favorite). Some healthcare providers recommend a simple homemade mixture of equal parts prune juice, chopped prunes, applesauce, and wheat bran, starting with one tablespoon a day and working up to four (again, not my go-to breakfast).

One caution: add fiber gradually. Ramping up too fast can cause bloating and gas, which discourages people from sticking with it. Slow and steady works better here.

Hydration

Without adequate fluid, stool dries out and becomes harder to pass. Mayo Clinic recommends 8 to 10 eight-ounce glasses of non-caffeinated fluids daily. This is especially important if you’re taking a fiber supplement, which needs water to do its job properly. Admittedly, this can be a real challenge for some people.

Physical Activity

Exercise stimulates the gut. Even light walking helps move things along, and the CDC recommends that seniors aim for about 30 minutes of cardiovascular exercise on most days, with a mix of muscle and bone-strengthening activities. The Nurses’ Health Study, which followed over 62,000 women, found that physical activity two to six times per week was associated with a 35% lower risk of constipation.

Scheduled Toileting

Taking advantage of the body’s natural gastrocolic reflex — the wave of colonic contractions triggered by eating — is a simple but effective strategy. Sitting on the toilet 15 to 30 minutes after a meal, particularly breakfast, can help train the bowel to move on a regular schedule. This is one of the most underutilized, zero-cost interventions in geriatric care.

Toilet Positioning

A simple footstool placed under the feet while on the toilet can make a meaningful difference. Raising the knees above hip level — mimicking a squatting position — straightens the angle between the rectum and the anus, making stool easier to pass. Some patients find this makes a real difference in comfort and completeness of evacuation.

Privacy and Routine

This one sounds almost too simple, but it matters: many older adults, particularly those in assisted living or with mobility limitations, feel rushed, embarrassed, or lack adequate privacy when trying to have a bowel movement. Stress and anxiety directly suppress gut motility. Ensuring that someone has enough time, privacy, and a comfortable setting is a legitimate therapeutic intervention, especially in care facility settings.

Biofeedback Therapy

For seniors whose constipation stems from difficulty coordinating the pelvic floor muscles — a condition called dyssynergic defecation — biofeedback therapy can be a game-changer. It uses electronic sensors and visual or auditory feedback to help patients learn to relax the correct muscles during a bowel movement. It’s non-invasive, has no side effects, and is particularly well-suited for people whose constipation hasn’t responded to diet and laxatives.

Pharmacological Approaches

When lifestyle changes aren’t enough and sometimes, they’re not, a range of medications are available, from gentle over-the-counter options to prescription treatments for stubborn cases. Here’s how they generally stack up, from mildest to strongest.

Fiber Supplements (Bulk-Forming Agents)

Products like psyllium (Metamucil), methylcellulose (Citrucel), and polycarbophil (FiberCon) work by absorbing water and adding bulk to stool, making it easier to pass. They’re generally safe for long-term use and are typically the first pharmaceutical step. The key is taking them with plenty of water; without adequate fluid, they can worsen constipation.

Stool Softeners

Docusate sodium (Colace) works by allowing water and fats to penetrate the stool, making it softer and easier to pass. It’s commonly used in post-surgical patients or anyone who needs to avoid straining — for example, after a heart attack or hemorrhoid surgery. It’s gentle and generally well tolerated, though evidence for its effectiveness as a standalone constipation treatment is modest.

Osmotic Laxatives

Polyethylene glycol — sold as MiraLAX — is widely considered the preferred osmotic laxative for older adults. It works by drawing water into the colon, softening the stool and stimulating movement. It’s tasteless, mixes easily into beverages, and has a favorable safety profile compared to alternatives like lactulose (which can cause bloating and gas) or magnesium-based products (which should be used cautiously in people with kidney disease). Daily use of PEG is considered safe and is quite common in geriatric practice. This is my personal option.

Milk of Magnesia (magnesium hydroxide) is another osmotic option that works well for many people, but should be used cautiously in anyone with impaired kidney function, as magnesium can accumulate and cause toxicity.

Stimulant Laxatives

Bisacodyl (Dulcolax) and senna (Senokot) work by stimulating nerve endings in the colon wall, triggering muscle contractions that push stool along. They’re effective but generally recommended for short-term use rather than daily reliance, due to concerns about dependency and potential effects on colon muscle function over time — though evidence on long-term harm is less alarming than once believed.

Suppositories and Enemas

For more immediate relief — or when oral treatments haven’t worked — glycerin or bisacodyl suppositories can sometimes trigger a bowel movement within minutes. Warm water or mineral oil enemas are typically reserved for fecal impaction. These are short-term rescue measures rather than ongoing management tools and should only be used with medical supervision.

Prescription Medications

For seniors with chronic constipation that doesn’t respond to over-the-counter options, several prescription medications have been approved. Linaclotide (Linzess) increases intestinal fluid secretion and gut motility; studies have included patients up to age 86 and demonstrated increased bowel movement frequency. Lubiprostone (Amitiza) works similarly. For patients on opioid pain medications whose constipation is directly caused by those drugs, a class of medications called peripherally acting mu-opioid antagonists — including methylnaltrexone (Relistor) and naloxegol (Movantik) — can counteract the constipating effects of opioids without reducing their pain-relieving benefits.

A Note on Medications That Cause Constipation

It’s worth pausing here to note that many medications commonly prescribed to older adults are themselves a major cause of constipation. Opioid pain medications are the biggest culprits, but the list also includes calcium channel blockers (used for blood pressure and heart conditions), certain antidepressants, antipsychotics, antihistamines, iron supplements, and some antihypertensives. If constipation is a new or worsening problem, a medication review with your doctor is one of the most productive first steps.

The Bottom Line (Sorry about the pun)

Bowel health in older adults is more nuanced than many people realize. “Normal” varies from person to person, and the goal isn’t to hit a daily number on a checklist — it’s to maintain whatever is comfortable and consistent for you, without pain or straining. When that starts to slip, you should take it seriously rather than dismissing it as just part of getting older.

The hierarchy of treatment is straightforward: start with lifestyle — fiber, fluids, exercise, and toileting routine. If that’s not enough, move to gentle over-the-counter options like fiber supplements and MiraLAX. If those don’t work, a physician can guide more targeted approaches, including prescription medications or biofeedback therapy.

And always, always tell your doctor about changes in your bowel habits — especially if they come with blood, pain, or weight loss. Your gut has a lot to say, and it’s worth listening.

Illustration generated by author using ChatGPT.

Sources

· PubMed / Annals of Internal Medicine — Bowel habit in relation to age and gender (National Health Interview Survey, 42,375 subjects) https://pubmed.ncbi.nlm.nih.gov/8572842/

· Mayo Clinic Community Health — Bowel habits as you age https://communityhealth.mayoclinic.org/featured-stories/bowel-habits-aging

· Harvard Health — Staying Regular https://www.health.harvard.edu/healthy-aging-and-longevity/staying-regular

· National Institute on Aging (NIH) — Concerned About Constipation? https://www.nia.nih.gov/health/constipation/concerned-about-constipation

· PubMed Central — Chronic Constipation in the Elderly Patient: Updates in Evaluation and Management https://pmc.ncbi.nlm.nih.gov/articles/PMC7272371/

· PubMed Central — Update on the Management of Constipation in the Elderly: New Treatment Options https://pmc.ncbi.nlm.nih.gov/articles/PMC2920196/

· PubMed Central — Constipation in Older Adults: Stepwise Approach to Keep Things Moving https://pmc.ncbi.nlm.nih.gov/articles/PMC4325863/

· HealthInAging.org — Caregiver Guide: Constipation Problems https://www.healthinaging.org/tools-and-tips/caregiver-guide-constipation-problems

· American Academy of Family Physicians (AAFP) — Management of Constipation in Older Adults (2015) https://www.aafp.org/pubs/afp/issues/2015/0915/p500.html

· American Academy of Family Physicians (AAFP) — Treatment of Constipation in Older Adults (2005) https://www.aafp.org/pubs/afp/issues/2005/1201/p2277.html

· Better Health While Aging — Constipation Treatment & Best Laxatives in Aging https://betterhealthwhileaging.net/how-to-prevent-and-treat-constipation-aging/

· Medical Daily — Chronic Constipation in Seniors: Complete Guide to Causes, Risks, and Safe Treatment Options https://www.medicaldaily.com/chronic-constipation-seniors-complete-guide-causes-risks-safe-treatment-options-474499

Illustration generated by author using ChatGPT

Medical Disclaimer

If you are experiencing a medical emergency, call 911 or your local emergency number immediately.

Cold Plunging: Real Physiology, Real Risks, and a Whole Lot of Hype

By John Turley

On May 4, 2026

In Medicine

Cold plunge tubs are popping up everywhere — gyms, spas, suburban backyards, and increasingly in high-end wellness retreats. Influencers post videos of themselves lowering into icy water with overly dramatic grimaces. Podcasters talk enthusiastically about dopamine surges and mental clarity. Biohackers track immersion times with the seriousness of laboratory researchers.

I have always been skeptical of what I call “fad medicine,” but cold plunging has become so widespread that it warrants a closer, more careful look. The question most people want answered is a simple one: is any of this real, is it at least minimally beneficial, or is it just expensive discomfort dressed up in scientific language?

The most honest answer is that it is a mix of all three. Some of the claims are grounded in solid physiology. Some are intriguing but still preliminary. And some have clearly outpaced the available evidence.

Cold-water immersion, often abbreviated as CWI, does have some legitimate scientific literature behind it. That said, the body of research is smaller, more recent, and less definitive than popular wellness culture would suggest. What follows is an attempt to separate what is known from what is plausible, what remains largely speculative, and what may be downright dangerous.

Long before cold plunging became a modern wellness trend, it existed as a long-standing human practice. References to cold water therapy appear in Egyptian medical texts dating back several thousand years. The Greek physician Hippocrates recommended cold water for pain relief and fatigue. Even Thomas Jefferson was said to have soaked his feet in cold water every morning for decades, believing it contributed to his health. The practice itself is not new but the attempt to study it systematically is.

For much of modern medical history, research on cold exposure focused primarily on its dangers—hypothermia, cardiac stress, and survival in extreme environments. Only in recent years has attention shifted toward possible benefits, driven largely by the explosion of public interest and researchers have acknowledged that the science is still catching up.

When it comes to physical effects, the strongest evidence relates to muscle recovery. Cold-water immersion has been shown to reduce soreness following intense exercise. The mechanism is relatively well understood. Exposure to cold causes blood vessels to constrict, which limits swelling and reduces inflammatory signaling. When normal circulation returns, metabolic byproducts are cleared more efficiently from muscle tissue. This is why athletes have relied on ice baths for decades.

However, this benefit comes with an important caveat. The same processes that reduce inflammation may also interfere with the body’s ability to adapt to strength training. Some studies suggest that regular cold exposure immediately after resistance exercise can blunt the molecular signals responsible for muscle growth. In practical terms, what helps you feel better in the short term may limit gains over the long term. For endurance athletes, this effect appears less pronounced, but for individuals focused on building strength and muscle mass, it is a meaningful consideration.

Cold exposure also has immediate and dramatic effects on the cardiovascular system. Immersion in cold water triggers what is often referred to as the “cold shock” response. Heart rate increases rapidly, blood pressure rises, and blood vessels in the skin constrict sharply, redirecting blood toward the body’s core. This is a powerful physiological stressor. Interestingly, once the body begins to recover, there is often a shift toward increased parasympathetic activity — the branch of the nervous system associated with rest and recovery. This shift is sometimes reflected in improved heart rate variability, a marker that correlates with cardiovascular resilience.

Observational studies of habitual cold-water swimmers suggest improvements in certain cardiovascular risk markers, including lipid profiles and oxidative stress. At the same time, it is important to recognize that even in well-adapted individuals, cold immersion still increases cardiac workload. The potential benefits and risks are not separate; they occur simultaneously. Whether long-term adaptation outweighs repeated short-term stress is still an open question.

Another frequently discussed area involves metabolism, particularly the activation of brown adipose tissue, or “brown fat.” Unlike white fat, which stores energy, brown fat burns energy to generate heat. Cold exposure stimulates this process, and some studies suggest it may improve insulin sensitivity and metabolic efficiency. A 2024 review published in GeroScience highlighted the possibility that cold exposure could reduce cardiometabolic risk. However, most of these studies are small and conducted under controlled conditions that may not reflect real-world behavior. While the findings are promising, they are not yet strong enough to support broad clinical recommendations.

More recently, researchers have begun exploring cellular-level effects. A 2025 study from the University of Ottawa found that repeated cold exposure influenced processes such as autophagy and apoptosis, which are involved in cellular repair and turnover. These mechanisms are often associated with aging and longevity. While the findings are intriguing, they were observed in a limited population and over a short time frame. At this stage, they represent an interesting possibility rather than a definitive conclusion.

The mental and emotional effects of cold plunging are perhaps the most widely discussed and the least clearly understood. Cold exposure triggers a surge in neurotransmitters, particularly norepinephrine and dopamine. These chemicals are associated with alertness, focus, and the experience of reward. Many individuals report feeling energized, clear-headed, and even euphoric after a cold plunge.

The key question, however, is whether these short-term effects translate into lasting improvements in mental health. Current evidence suggests that while immediate mood elevation is real, long-term benefits are less certain. Systematic reviews have found that the evidence for sustained reductions in anxiety or depression is inconclusive. It is also worth noting that some of the perceived benefit may reflect a placebo effect, which, while real, complicates interpretation.

There is somewhat stronger evidence supporting short-term stress reduction. Cold exposure acts as a controlled stressor, forcing the body to adapt. This concept, known as hormesis, suggests that small, manageable stressors can enhance resilience over time. Some studies have found that cold-water immersion is associated with reduced stress levels, improved sleep, and enhanced subjective well-being for several hours following exposure. However, these effects appear to be time-limited, and it is not yet clear whether they accumulate in a meaningful way over longer periods.

Claims regarding immune function are among the most popular and the least substantiated. A frequently cited study reported that individuals who took cold showers experienced fewer sick days. However, cold showers are not the same as full immersion, and reduced absenteeism is not a direct measure of immune performance. Studies examining cold-water immersion have produced inconsistent results. Some show changes in immune markers, while others do not. Most focus on laboratory measurements rather than actual illness outcomes. At present, the evidence for immune enhancement remains inconclusive.

For older adults, the picture becomes more complex. Aging affects the body’s ability to regulate temperature. The capacity to generate heat declines, sensitivity to cold may be reduced, and chronic conditions or medications can further impair thermoregulation. What might be an invigorating experience for a younger individual can pose a genuine risk for someone in their later decades.

This does not mean cold exposure is entirely off the table, but it does mean the approach must be modified. Milder temperatures, shorter durations, and greater caution are essential. The margin for error is smaller, and symptoms such as dizziness, confusion, or irregular heartbeat may be delayed. The risk-benefit balance shifts noticeably with age.

There are also groups for whom cold plunging is best avoided altogether. Individuals with cardiovascular disease, particularly those with arrhythmias or a history of heart attack, face increased risk due to the sudden cardiovascular stress. People with peripheral vascular disease or Raynaud’s phenomenon may experience harmful levels of vasoconstriction. Those with diabetes and neuropathy may have impaired sensation and circulation, increasing the risk of injury. Individuals with respiratory conditions such as severe asthma may be vulnerable to cold-induced bronchospasm. Additional caution applies to those with rare conditions such as cold urticaria or cryoglobulinemia, as well as anyone recovering from recent surgery.

It is important to acknowledge what the evidence does not support. Claims that cold plunging significantly slows aging are not backed by clinical data. The idea that it produces long-term immune enhancement remains unproven. Even the metabolic benefits, while biologically plausible, appear modest and context-dependent.

Another challenge is the lack of standardization in the research itself. Studies vary widely in water temperature, duration of exposure, frequency, and participant characteristics. This makes it difficult to compare results or draw firm conclusions. In many cases, researchers are effectively studying different interventions under the same label.

The bottom line is that cold plunging is neither a miracle cure nor pure nonsense. It produces real physiological effects, some of which are beneficial, particularly in the context of athletic recovery. For healthy individuals, it may offer short-term improvements in mood, stress, and perceived well-being. At the same time, its long-term benefits remain uncertain, and its risks are not trivial for certain populations.

For those who are curious and in good health, a gradual and cautious approach may be reasonable. Starting with cool water and progressing slowly allows the body to adapt while minimizing risk. A visit with a physician is still advised before starting any new regimen.

For individuals with underlying medical conditions, particularly cardiovascular disease, the prudent course is to consult a physician before attempting any cold water immersion.

Cold plunging clearly does something. The challenge is that we are still in the early stages of understanding exactly what that “something” is, how durable it may be, and for whom it is most appropriate. In medicine, that places it in a familiar category—an intervention that is interesting, potentially useful, possibly harmful in some cases, but not yet fully defined.

Illustration generated by author using ChatGPT.

Sources

1. Effects of cold-water immersion on health and wellbeing: A systematic review and meta-analysis — PLOS One (2025)

2. Cold-water plunging health benefits — Mayo Clinic Health System (2024)

3. Cold plunges: Healthy or harmful for your heart? — Harvard Health (2025)

4. The untapped potential of cold water therapy for healthy aging — PMC / GeroScience (2024)

5. Health effects of voluntary exposure to cold water — PMC / Int J Circumpolar Health (2022)

6. Cold plunges actually change your cells — ScienceDaily / University of Ottawa (2025)

7. The health benefits (and risks) of cold plunges — Advisory Board (2025)

8. What are the health benefits of a cold plunge? Scientists vet the claims — NPR (2023)

9. The benefits of cold-water immersion therapy — UF Health Jacksonville (2024)

10. Cold and longevity: Can cold exposure counteract aging? — ScienceDirect (2025)

11. Ice bath for seniors: Safety and age-appropriate cold therapy — PlungeChill (2025)

12. What seniors should know before trying a cold plunge — SilverSneakers (2025)

13. Ice baths over 50, according to a geriatrician — Parade (2023)

14. Ice baths and saunas: Are the latest health trends bad for your lungs? — American Lung Association

15. Sauna and cold plunge for seniors 60+: Safe protocols guide 2026 — Calore Health

16. Cold plunge benefits, risks, and who should avoid — Dr. Axe (2024)

Medical Disclaimer

If you are experiencing a medical emergency, call 911 or your local emergency number immediately.

Supplement Smarts: What Seniors Should Know Before Reaching for That Bottle

By John Turley

On April 9, 2026

In Medicine

Walk through the supplement aisle of any pharmacy and you’ll find shelf after shelf of promises — stronger bones, sharper memory, less joint pain, better sleep. Americans spend roughly $60 billion a year on dietary supplements, and seniors are among the most enthusiastic buyers. But which of these products actually deliver, which are harmless but ineffective, and which could do real damage? The answers are more nuanced than the marketing suggests.

Older adults are often drawn to supplements because aging changes appetite, digestion, medication use, and nutrient absorption. But the general rule is simple: supplements work best when they fill a documented gap, and they are least useful when they are taken as a broad “insurance policy” by otherwise well-nourished people. Let’s take a closer look.

First, a ground rule that applies to everything in this article: dietary supplements are not FDA-approved drugs. The FDA treats them more like foods, meaning manufacturers don’t have to prove effectiveness before selling them. Quality control also varies widely — what’s on the label may not always match what’s in the bottle. As a result, the scientific evidence behind many supplements is limited or inconsistent. When shopping, look for products with a USP (United States Pharmacopeia) verified mark, which indicates independent testing for identity, purity, and potency.

The Genuinely Helpful Ones

Vitamin D and Calcium are probably the most well-supported supplements for older adults. Bone loss accelerates with age, and these two nutrients work as a team — calcium provides the raw material for bone, while vitamin D helps the body absorb it. The National Institute on Aging recommends 600 IU of vitamin D daily for adults aged 51–70, and 800 IU for those over 70. Most seniors don’t get enough from diet or sun exposure alone, making supplementation genuinely sensible for many people. This is especially true for prople with documented deficiency or osteoporosis risk. One important caveat: don’t go overboard. Too much vitamin D can cause calcium to build up in the blood, potentially harming the kidneys and blood vessels.

Vitamin B12 is another legitimate priority; Up to 15 percent of older adults may bedeficient.. Older adults are prone to B12 deficiency not because they eat less of it, but because the stomach produces less acid with age, and stomach acid is needed to release B12 from food. Those taking acid-blocking medications are at even higher risk. Deficiency can cause nerve damage and anemia. The good news is that the form of B12 in supplements is absorbed without needing stomach acid, making supplements effective where food sources may fall short.

Omega-3 fatty acids, found in fish oil, have earned a solid reputation for lowering triglycerides — a type of blood fat linked to heart disease. A large study of over 400,000 people found associations between fish oil use and improved cholesterol profiles. However, the picture is more complicated for other claimed benefits. Evidence for omega-3s preventing dementia is mixed, and some research suggests fish oil can actually raise LDL (“bad”) cholesterol in certain people, so monitoring is wise. For those who can’t eat fatty fish regularly, fish oil is a reasonable backup — just don’t expect miracles beyond the triglyceride benefit.

Melatonin has moderate scientific support for improving sleep, which is a chronic issue for many older adults. It’s particularly helpful for resetting disrupted sleep cycles. The key is using it at low doses — often 0.5 to 3 mg is sufficient, though most over-the-counter products contain far more. It’s generally well tolerated but should not replace evaluation of underlying sleep disorders.

Creatine and protein supplements may sound like something only gym rats need, but research increasingly supports their role in combating sarcopenia — the age-related loss of muscle mass that can lead to falls and loss of independence. A 2024 Stanford review found that creatine supplementation, combined with resistance training, can meaningfully preserve muscle in adults over 65. Branched-chain amino acids (BCAAs) can play a supporting role in certain situations, particularly when protein intake from food is inadequate. Vegans should pay particular attention to protein intake.

The Ambiguous Middle Ground

Glucosamine and chondroitin are among the most popular supplements for joint pain, and the scientific debate around them has been going on for decades. These are naturally occurring compounds in cartilage, and the theory is that supplementing them may slow joint deterioration in osteoarthritis. A 2024 systematic review of 146 studies found that over 90% of the studies reported positive outcomes — impressive on its face. But the landmark NIH-funded GAIT trial told a more sobering story: glucosamine and chondroitin, alone or together, were no more effective than a placebo for most people with knee osteoarthritis. The exception was a subgroup with moderate-to-severe pain, who did show moderate improvement. Safety is generally good, but those on blood thinners like warfarin should be careful, as glucosamine may affect clotting.

Turmeric and curcumin have generated enormous popular interest, and there’s at least a plausible scientific basis for the excitement. Curcumin, the active compound in turmeric, is a potent anti-inflammatory and antioxidant. Multiple clinical trials support some benefit for knee pain, and some research suggests potential benefits for cognitive health. However, curcumin is poorly absorbed on its own, which is why many products add black pepper (piperine) or use enhanced delivery formulations. The overall evidence, while promising, is still described as “mixed or low quality” by most reviewers. If you do try it, look for a formulation with enhanced bioavailability and give it at least 4–8 weeks and be aware that it may cause gastrointestinal symptoms.

Saw palmetto is widely used by older men for symptoms of benign prostatic hyperplasia (BPH) — the enlarged prostate that causes frequent urination. A 2024 updated Cochrane review found some evidence of limited benefit for urinary symptoms for some men, though the results are inconsistent and most mainstream urology guidelines do not formally recommend it. It’s generally well tolerated. Men using it should still get their prostate checked regularly and not assume saw palmetto rules out other conditions.

Magnesium has had a social media moment, with enthusiastic claims about better sleep, improved mood, and reduced muscle cramps. The actual science is more cautious — there’s limited evidence for magnesium supplements providing any of these benefits in people who aren’t already deficient. That said, deficiency is relatively common in older adults, and correction of a true deficiency can absolutely help. A blood test can tell you if you actually need it.

Multivitamins present a genuine paradox. They’re the most commonly taken supplement category, often recommended by physicians as a nutritional safety net. And for seniors with reduced appetite or limited dietary variety, that logic holds. But large, well-designed studies have found limited evidence that multivitamins improve longevity or prevent major diseases in otherwise healthy older adults. A newer 2024 analysis from the COSMOS trial suggests some modest benefit for cognitive function. Senior-specific multivitamins are preferred — they typically contain more vitamin D and B12 and less or no iron, which reflects the actual needs of older adults.

The Ones That Raise Red Flags

Iron supplements deserve special caution in older men and post-menopausal women. Unless there’s a documented deficiency confirmed by blood testing, taking iron supplements can be harmful. In men, iron overload is a genuine risk, and about twice as many men carry the gene for hereditary hemochromatosis (a condition where the body absorbs too much iron) as carry the gene for iron deficiency. Excess iron has been linked to liver damage and may raise cancer risk. Senior-specific multivitamins wisely contain little or no iron for exactly this reason.

High-dose Vitamin A is another potential problem. The liver’s ability to clear vitamin A decreases with age, and older adults absorb more of it. Doses above recommended daily values can accumulate to toxic levels, potentially harming the liver. This is specifically the retinol form of vitamin A. Beta-carotene from plant sources is much safer. Check your multivitamin label carefully.

High dose Vitamin B6 can cause nerve damage, balance problems, and sensory neuropathy when taken over long periods but is safe at recommended levels.

Many supplements claim to improve memory or prevent dementia. Unfortunately, the evidence is generally weak. Fish oil, ginkgo biloba, and other popular products have not demonstrated clear benefits for preventing cognitive decline in controlled studies. Some research suggests that long-term supplementation with B vitamins might slow certain aspects of cognitive decline in specific populations, but results remain inconsistent.

St. John’s Wort is widely used for mild depression, but it comes with a serious warning: it interacts with a long list of medications, including antidepressants, blood thinners, heart medications, and antiretroviral drugs. For seniors managing multiple conditions with multiple prescriptions, this herb is particularly risky. Ginkgo biloba carries similar drug interaction concerns, especially around bleeding risk when combined with blood thinners or aspirin.

High-dose antioxidants — vitamins A, C, and E taken in large amounts — have largely failed to deliver on their promise of preventing heart disease and cancer. The US Preventive Services Task Force does not recommend these for prevention. In some cases, large antioxidant supplements may actually interfere with the body’s natural disease-fighting mechanisms.

The Bottom Line

Given the mixed evidence, a sensible approach to supplements includes several principles:

Food first. A balanced diet usually provides most necessary nutrients.
Test before supplementing. Blood tests can identify deficiencies such as B12 or Vitamin D.
Avoid megadoses. Excessive intake of vitamins can cause toxicity.
Check medication interactions. Many supplements interact with common drugs, including blood thinners.
Treat supplements like medications. They should have a clear purpose and measurable benefit.

Supplements that address documented deficiencies or fill genuine dietary gaps — vitamin D, B12, calcium, omega-3s — offer the best evidence for benefit in seniors. Joint supplements like glucosamine and turmeric may help some people, though the evidence is mixed enough that a try-and-see approach (with a 2–3 month window to assess benefit) is reasonable. And several common supplements, particularly iron in unsupervised use, high-dose vitamin A, and certain herbals in combination with medications, carry risks that are easy to overlook because they’re sold without a prescription.

I always advised my patients to bring all their supplement bottles to at least one visit each year and to bring any medicines prescribed by specialists. Physicians can spot dangerous overlaps, flag interactions with your prescriptions, and tell you if what you’re taking makes sense for you. Many seniors never hear a list of side effects for supplements the way they do for prescription drugs — and they often assume that means there aren’t any. That assumption, unfortunately, can be costly.

Illustration generated by author using ChatGPT.

Sources

Kaufman MW et al. Nutritional Supplements for Healthy Aging: A Critical Analysis Review. American Journal of Lifestyle Medicine, 2024.

National Institute on Aging. Dietary Supplements for Older Adults.

National Institute on Aging. Vitamins and Minerals for Older Adults.

Linus Pauling Institute, Oregon State University. Older Adults — Micronutrient Information Center.

Baden KER et al. The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review. Nutrients, 2025.

National Center for Health Research. Glucosamine Supplements: Do They Work and Are They Safe?

BodySpec. Supplements for Joint Health: 2025 Evidence-Based Guide.

UCHealth Today. Dietary Supplements: Are These 14 Common Vitamins and Supplements Beneficial or a Waste of Money?

Cleveland Clinic. Dietary Supplements Compound Health Issues for Older Adults.

FDA. Mixing Medications and Dietary Supplements Can Endanger Your Health.

NIH Office of Dietary Supplements. Iron — Health Professional Fact Sheet.

NIH Office of Dietary Supplements. Multivitamin/Mineral Supplements — Health Professional Fact Sheet.

Foods (MDPI). Food Supplements and Their Use in Elderly Subjects — Challenges and Risks. 2024.

PMC. Improving Cognitive Function with Nutritional Supplements in Aging: A Comprehensive Narrative Review. 2023.

Memorial Healthcare System. Herbal Supplements and Prescription Drugs: Know the Risks. 2024.

WebMD. Saw Palmetto: Overview, Uses, Side Effects, Precautions.

________________________________________________

Medical Disclaimer

If you are experiencing a medical emergency, call 911 or your local emergency number immediately.

Lipoprotein(a): The Hidden Genetic Risk Factor That’s Finally Being Recognized

By John Turley

On March 9, 2026

In Medicine

For decades, most doctors, me included, focused on the usual suspects when assessing heart disease risk: LDL cholesterol, HDL cholesterol, triglycerides, blood pressure, and lifestyle factors like smoking, activity, and diet. But lurking in the background was another player that most of us didn’t routinely check and most patients had never heard of—lipoprotein(a), abbreviated as Lp(a) and pronounced “L-P-little-A.”

Here’s the sobering reality: about one in five people worldwide have elevated Lp(a) levels, and if you’re among them, your risk of heart attack or stroke roughly doubles or triples. Yet until recently, most clinical guidelines didn’t even recommend testing for it. Why? Because there wasn’t much doctors could do about it even if we found it. That’s changing now, and the story of Lp(a) offers a window into how medicine sometimes waits for treatment options before fully embracing a diagnostic test.

What Exactly Is Lipoprotein(a)?

Lp(a) is structurally similar to LDL cholesterol—both are cholesterol-carrying particles—but Lp(a) has an extra protein component called apolipoprotein(a), or apo(a), that makes it particularly troublesome. The structure of this protein varies dramatically between individuals due to differences in genetic sequences, and the specific variant you inherit from your parents determines your Lp(a) level for life.

Unlike LDL cholesterol, which rises with age and responds to diet and exercise, your Lp(a) level remains largely constant throughout your lifetime. Eating better, exercising more, losing weight—none of the lifestyle interventions that work wonders for other cardiovascular risk factors will budge your Lp(a). It’s entirely genetic. There’s also significant variation across populations, with individuals of African descent tending to have higher average Lp(a) levels compared to people of White or Asian backgrounds, though the clinical implications of these differences are still not well understood.

Getting Tested: Who Should Do It and How Does It Works

The blood test for Lp(a) isn’t part of a routine cholesterol panel—your doctor has to specifically order it. So, who should be tested? Current recommendations focus on people with a family history of high Lp(a), those with a personal or family history of premature heart disease (cardiovascular events before age 55 in men or 65 in women), and anyone diagnosed with familial hypercholesterolemia, a genetic condition where the body poorly recycles LDL cholesterol. About a third of people with familial hypercholesterolemia also have high Lp(a), compounding their cardiovascular risk significantly.

Because Lp(a) levels don’t change over time, a single test is all you need. Results can be reported in two different units—milligrams per deciliter (mg/dL) or nanomoles per liter (nmol/L)—and there’s no universal agreement on what constitutes a risky level. Most American guidelines use a threshold of ≥50 mg/dL or ≥125 nmol/L as indicating increased cardiovascular risk, with levels below 30 mg/dL generally considered normal.

What High Lp(a) Means for Your Health

The evidence linking elevated Lp(a) to cardiovascular disease has become increasingly compelling over the past two decades. People with high Lp(a) face a two to threefold increased risk of heart attack and aortic valve disease. For those with extremely elevated levels above 180 mg/dL, the cardiovascular risk approaches that of people with untreated familial hypercholesterolemia (genetic extremely high cholesterol), which is notoriously dangerous.

Beyond heart attacks and valve problems, elevated Lp(a) has been linked to peripheral arterial disease (clogged arteries) and aortic aneurysms. What makes it particularly insidious is that it contributes to what researchers call “residual cardiovascular risk”—meaning it raises your chances of a cardiovascular event even when your LDL cholesterol is well controlled. You could be doing everything right by traditional measures and still be at elevated risk if your Lp(a) is high.

A large multi-ethnic study following nearly 28,000 people for an average of 21 years found that higher Lp(a) levels were consistently associated with greater cardiovascular disease risk across different ethnic groups and in both men and women. The mechanism involves both promoting arterial plaque buildup and increasing blood clot formation—a double threat to cardiovascular health.

Current Management Options: Limited but Important

This is where the story gets frustrating. For years, the honest answer to “what can I do about my high Lp(a)?” has been: not much directly, but a few things indirectly.

While lifestyle changes won’t affect your Lp(a) numbers, people with high levels should still follow all standard heart-healthy practices—physical activity, good nutrition, adequate sleep, avoiding smoking, and maintaining a healthy weight. The logic is straightforward: if you can’t eliminate one major risk factor, be more diligent about controlling all the others.

People with high Lp(a) may also benefit from more aggressive LDL cholesterol treatment, even if their LDL is already in a normal range. Some injectable cholesterol medications can lower Lp(a) by about 20% in some patients in addition to their primary effect on LDL. This helps overall cardiovascular risk even if it doesn’t fully address the Lp(a) problem.

For the most severe cases, the only FDA-approved treatment specifically targeting Lp(a) lipoprotein is apheresis which filters apolipoprotein-containing particles from the blood, achieving over 50% reduction. But the reductions are temporary, the procedure is similar to dialysis in its time demands, and it’s expensive and reserved for only the most extreme situations. It’s not a practical solution for the millions of people with moderately elevated levels.

The Treatment Revolution: New Therapies on the Horizon

Here’s where things get genuinely exciting. After decades of essentially no targeted treatment, five promising new therapies are now in advanced clinical development.

Four are RNA-based therapies that work by silencing the gene responsible for producing apolipoprotein(a) in the liver thereby preventing Lp(a) formation at its source. All are engineered to be taken up specifically by liver cells, where Lp(a) is made to minimize side effects elsewhere.

Early trial results have been remarkable. One drug, given as a monthly injection under the skin, has reduced Lp(a) levels by about 80%, with 98% of participants achieving levels below the risk threshold of 50 mg/dL. A phase 3 trial enrolling over 8,300 patients is expected to report results sometime in 2026, potentially leading to regulatory approval shortly after.

Other drugs have shown even more dramatic results, with one achieving a 93.9% reduction in Lp(a) with a single dose, with the effect persisting above 90% even at 360 days after just one injection.

There’s also an oral medication in development which works by preventing the apo(a) protein from assembling into Lp(a) particles in the first place. Taken daily as a pill, it has shown reductions of 63-65%—less dramatic than the RNA-based therapies, but potentially preferable for patients who want to avoid injections entirely.

The Critical Caveat

While these medications dramatically lower Lp(a) levels, we don’t yet have definitive proof that lowering Lp(a) will prevent heart attacks and strokes. That sounds counterintuitive—if high Lp(a) causes cardiovascular disease, then lowering it should help—but medicine requires rigorous evidence from randomized controlled trials. The FDA won’t approve these drugs based solely on their ability to improve a lab value; they need to demonstrate actual clinical benefit. Large outcome trials are underway and we should have answers within the next few years.

Where Things Stand Now

The story of Lp(a) reflects a broader tension in medicine: when should we test for something we can’t yet treat? For decades, many argued against routine screening precisely because no targeted therapies existed. That calculus has shifted. Recent reviews have concluded that the benefits of early detection now outweigh the risks, even though specific Lp(a)-lowering drugs are not yet approved, because early knowledge allows for more aggressive management of other risk factors.

For the roughly 20-25% of people with elevated Lp(a), the next few years could bring transformative options. If you fall into one of the higher-risk groups and have never been tested, it’s worth asking your doctor whether screening makes sense. The treatment landscape for Lp(a) is changing faster than it has in decades, and knowing your number today puts you in a much better position to act when those new options arrive.

Illustration generated by the author using ChatGPT.

Sources

American Heart Association. (n.d.). Lipoprotein (a). https://www.heart.org/en/health-topics/cholesterol/genetic-conditions/lipoprotein-a

American Heart Association. (n.d.). Lipoprotein (a) meaning and how does it impact my heart health? https://www.heart.org/en/health-topics/cholesterol/genetic-conditions/lipoprotein-a-risks

Beck, D. L. (2025). Lipoprotein(a): An independent risk factor for CV disease. American College of Cardiology. https://www.acc.org/latest-in-cardiology/articles/2025/12/01/01/feature-lipoprotein-a

Centers for Disease Control and Prevention. (2025). About lipoprotein (a). https://www.cdc.gov/heart-disease-family-history/about/about-lipoprotein-a.html

Cleveland Clinic. (2025). Novel siRNA reduces lipoprotein(a) by more than 90% for 48 weeks. https://consultqd.clevelandclinic.org/novel-sirna-reduces-lipoproteina-by-more-than-90-for-48-weeks

Corliss, J. (2025). Lipoprotein(a): An update on testing and treatment. Harvard Health Publishing. https://www.health.harvard.edu/heart-health/lipoproteina-an-update-on-testing-and-treatment

Grundy, S. M., & Stone, N. J. (2022). Lipoprotein(a): A genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: A scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 42(1), e48-e60. https://www.ahajournals.org/doi/10.1161/ATV.0000000000000147

Katsiki, N., et al. (2023). An update on lipoprotein(a): The latest on testing, treatment, and guideline recommendations. American College of Cardiology. https://www.acc.org/Latest-in-Cardiology/Articles/2023/09/19/10/54/An-Update-on-Lipoprotein-a

Lombardi, A., et al. (2024). Lipoprotein (a): Underrecognized risk with a promising future. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11607505/

Lombardo, C., et al. (2025). Lp(a)-lowering agents in development: A new era in tackling the burden of cardiovascular risk? PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12115060/

Managed Healthcare Executive. (2025). New therapies on the way to lower Lp(a), a cardiovascular risk factor. https://www.managedhealthcareexecutive.com/view/new-therapies-on-the-way-to-lower-lp-a-a-cardiovascular-risk-factor

Papathanasiou, M., et al. (2025). Current clinical trials for treating elevated lipoprotein(a). PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12282488/

Sabatine, M. S., et al. (2025). Lipoprotein(a) as a pharmacological target: Premises, promises, and prospects. Circulation. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.069210

StatPearls. (2024). Lipoprotein A. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK570621/

Tsimikas, S., et al. (2025). Pelacarsen: Mechanism of action and Lp(a)-lowering effect. ScienceDirect. https://www.sciencedirect.com/science/article/pii/S1933287425003228

Tsimikas, S., et al. (2025). Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening. ScienceDirect. https://www.sciencedirect.com/science/article/pii/S2666667725000182

Wong, N. D., et al. (2024). Lipoprotein(a) and long-term cardiovascular risk in a multi-ethnic pooled prospective cohort. Journal of the American College of Cardiology. https://www.jacc.org/doi/10.1016/j.jacc.2024.02.031

Zambon, A., et al. (2023). Lipoprotein(a) as a risk factor for cardiovascular diseases: Pathophysiology and treatment perspectives. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10531345/

Fecal Microbiota Transplantation: When Waste Becomes Therapy

By John Turley

On February 4, 2026

In Medicine

Today I’m going to talk about something that may sound unbelievable and maybe even a little gross—fecal transplant. Yes, it’s exactly what it sounds like. Getting a transplant of someone else’s poop.

The human gut contains trillions of microorganisms—bacteria, viruses, fungi—living in a complex ecosystem that influences everything from digestion to immune function. This is called the microbiome. When this ecosystem gets disrupted, the consequences can range from uncomfortable to life-threatening. Enter one of medicine’s most counterintuitive treatments: fecal microbiota transplantation, or FMT, where stool from a healthy donor is transferred to a patient to restore a healthy community of gut microbes.

What Is FMT

The basic idea is simple: if someone’s microbiome has been badly disrupted (most commonly by repeated antibiotic exposure), replacing it with a balanced microbial ecosystem can help the gut recover. At its core, FMT is taking fecal matter from a healthy donor and introducing it into a patient’s gastrointestinal tract. But it’s not the solid waste itself that matters; it’s the billions of beneficial bacteria and other microorganisms living in that material. Think of it as a probiotic treatment on steroids, delivering an entire functioning ecosystem rather than just a few select bacterial strains.

The gut microbiome plays crucial roles in digestion, vitamin production, immune system regulation, and even protection against harmful pathogens. When antibiotics, illness, or other factors devastate this ecosystem, dangerous bacteria like Clostridioides difficile (C. diff) can take over, causing severe diarrhea, inflammation, and potentially fatal infections.

The Clinical Track Record

While it may sound like “weird science”, FMT has been around for centuries. It was used in ancient Chinese medicine in a formulation called “yellow soup“ to treat food poisoning and intractable diarrhea. It was used as early as the 16th century in Europe to treat sick farm animals, particularly sheep and cattle.

FMT’s most dramatic success story involves C. diff infections, particularly the recurrent cases that don’t respond to antibiotics. Multiple randomized controlled trials have shown FMT to be remarkably effective—with cure rates often exceeding 80-90% for recurrent C. diff infections, compared to roughly 25-30% for continued antibiotic therapy. A landmark 2013 study reported in the New England Journal of Medicine was stopped early because FMT was so dramatically superior to standard treatment that continuing to withhold it from the control group seemed unethical.

Beyond C. diff, researchers are investigating FMT for inflammatory bowel diseases like ulcerative colitis and Crohn’s disease, with mixed but occasionally promising results. Some studies have shown potential for ulcerative colitis, with remission rates around 24-27%. The research into Crohn’s disease, irritable bowel syndrome, metabolic disorders, and even neurological conditions is ongoing but less conclusive. The FDA currently considers FMT an investigational treatment for most conditions except recurrent C. diff, where it’s become a recognized therapeutic option.

How It Works

The actual process of FMT can use several routes. The most common approaches involve colonoscopy, where the donated material is delivered directly to the colon, or through nasogastric or nasoduodenal tubes that thread through the nose down to the small intestine. More recently, oral capsules containing frozen, encapsulated donor stool have become available, offering a less invasive alternative that patients often prefer.

Before the transplant, the donated stool is carefully processed. It’s typically mixed with a saline solution and filtered to remove large particles while preserving the microbial communities. The resulting liquid suspension is what gets delivered to the patient. For frozen preparations, this material is mixed with a cryoprotectant, frozen at extremely cold temperatures, and can be stored for months before use.

The preparation isn’t just about the donor material—patients often undergo their own preparation. Many protocols include antibiotics to reduce the overgrowth of harmful bacteria before the transplant, followed by bowel cleansing similar to what you’d do before a colonoscopy. The idea is to create a relatively clean slate where the new microbial ecosystem can establish itself.

Sources of Donor Material

This brings us to one of the most critical aspects: donor selection and screening. Not just anyone can donate stool for medical use. The screening process is extensive and rigorous, rivaling or exceeding the scrutiny applied to blood donation.

Donors undergo detailed health questionnaires covering everything from recent travel and antibiotic use to gastrointestinal symptoms and risk factors for infectious diseases. They provide blood and stool samples that are tested for a long list of potential pathogens: C. diff, Helicobacter pylori, parasites, hepatitis A, B, and C, HIV, syphilis, and various other bacteria and viruses. The FDA issued guidance requiring additional testing for multi-drug resistant organisms after several patients contracted serious infections from FMT.

Donors generally fall into two categories: directed donors and universal donors. Directed donors are typically family members or friends who undergo screening and provide stool specifically for one patient. Universal donors go through the same rigorous screening but provide samples that can be used for multiple patients. These universal donors often work with stool banks—specialized facilities that collect, process, screen, and distribute donor material to healthcare providers.

The largest stool bank in the United States, OpenBiome, was founded in 2012 and has processed material from thousands of donors for tens of thousands of treatments. They report that only about 2-3% of volunteer donors successfully make it through the screening process, highlighting just how selective the criteria are. These banks have made FMT more widely available, eliminating the need for individual healthcare facilities to find and screen their own donors.

The Balance of Promise and Caution

While FMT represents a genuine breakthrough for recurrent C. diff infections, the medical community remains appropriately cautious about expanding its use. The FDA regulates FMT and has expressed concerns about potential risks, particularly after cases where patients developed serious infections from inadequately screened donors. There questions about the long-term effects of introducing another person’s microbiome, and there are theoretical concerns about transmitting conditions or predispositions we don’t fully understand.

The research into FMT for conditions beyond C. diff continues, but many trials have shown modest or inconsistent results. The microbiome’s role in health and disease is incredibly complex, and what works dramatically for one condition may not translate to others. Still, the fundamental insight—that our gut microbiome profoundly influences our health and that we can therapeutically manipulate it—has opened potential new avenues in medicine.

Sources

1. van Nood, E., et al. (2013). “Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile.” New England Journal of Medicine, 368(5), 407-415. https://www.nejm.org/doi/full/10.1056/NEJMoa1205037

2. U.S. Food and Drug Administration. “Fecal Microbiota for Transplantation: Safety Information.” https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fecal-microbiota-transplantation-safety-information

3. Cammarota, G., et al. (2017). “European consensus conference on faecal microbiota transplantation in clinical practice.” Gut, 66(4), 569-580. https://gut.bmj.com/content/66/4/569

4. Moayyedi, P., et al. (2015). “Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.” Gastroenterology, 149(1), 102-109. https://www.gastrojournal.org/article/S0016-5085(15)00381-5/fulltext

5. Kelly, C.R., et al. (2016). “Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.” Gastroenterology, 150(1), 276-290. https://www.gastrojournal.org/article/S0016-5085(15)01626-7/fulltext

6. OpenBiome. “Our Process: Screening.” https://www.openbiome.org/safety

7. Quraishi, M.N., et al. (2017). “Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.” Alimentary Pharmacology & Therapeutics, 46(5), 479-493. https://onlinelibrary.wiley.com/doi/full/10.1111/apt.14201

Illustration generated by author using Midjourney

America’s Healthcare Paradox: Why We Pay Double and Get Less

By John Turley

On January 5, 2026

In Commentary, Medicine

The healthcare debate in America often circles back to a fundamental question: should we move toward a single-payer system, or is our current mixed public-private model the better path forward? It’s a conversation that gets heated quickly, but when you strip away the politics and look at how different systems actually function around the world, some interesting patterns emerge.

What We Mean by Single-Payer

A single-payer healthcare system means that one entity—usually the government or a government-related organization—pays for all covered healthcare services. Doctors and hospitals can still be private (and usually are), but instead of dealing with dozens of different insurance companies, they bill one source. It’s a lot like Medicare, which is why proponents often call it “Medicare-for-all”.

The key thing to understand is that single-payer isn’t necessarily the same as socialized medicine. In Canada’s system, for instance, the government pays the bills, but doctors are largely in the private sector and hospitals are controlled by private boards or regional health authorities rather than being part of the national government. Compare that to the UK’s National Health Service, where many hospitals and clinics are government-owned and many doctors are government employees.

America’s Current Patchwork

The United States operates what might charitably be called a “creative” approach to healthcare—a complex mix of employer-sponsored private insurance, government programs like Medicare, Medicaid and the VA system, individual marketplace plans, and direct out-of-pocket payments. Government already pays roughly half of total US health spending, but benefits, cost-sharing, and networks vary widely between plans, with little overall coordination. In 2023, private health insurance spending accounted for 30 percent of total national health expenditures, Medicare covered 21 percent, and Medicaid covered 18 percent. Most of the remainder was either paid out of pocket by private citizens or was written off by providers as uncollectible.

Here’s where it gets expensive. U.S. health care spending grew 7.5 percent in 2023, reaching $4.9 trillion or $14,570 per person, accounting for 17.6 percent of the nation’s GDP, and national health spending for 2024 is expected to have exceeded $5.3 trillion or 18% of GDP, and health spending is expected to grow to 20.3 percent of GDP by 2033.

For a typical American family, the costs are real and rising. In 2024, the estimated cost of healthcare for a family of four in an employer-sponsored health plan was $32,066.

The European Landscape

Europe doesn’t have one healthcare model—it has several, and they’re all quite different from what we have in the States. Most of the 35 countries in the European Union have single-payer healthcare systems, but the details vary considerably.

Countries like the UK, Sweden, and Norway operate what are essentially single-payer systems where it is solely the government who pays for and provides healthcare services and directly owns most facilities and employs most clinical and related staff with funds from tax contributions. Then you have countries like Germany, and Belgium that use “sickness funds”—these are non-profit funds that don’t market, cherry pick patients, set premiums or rates paid to providers, determine benefits, earn profits or have investors. They’re quasi-public institutions, not private insurance companies like we know them in America. Some systems, such as the Netherlands or Switzerland, rely on mandatory individually purchased private insurance with tight regulation and subsidies, achieving universal coverage with a structured, competitive market.

The French System

France is particularly noted for a successful universal, government-run health insurance system usually described as a single-payer with supplements. All legal residents are automatically covered through the national health insurance program, which is funded by payroll taxes and general taxation.

Most physicians and hospitals are private or nonprofit, not government employees or facilities. Patients generally have free choice of doctors and specialists, though coordinating through a primary care physician improves access and reimbursement. The national insurer pays a large portion of medical costs (often 70–80%), while voluntary private supplemental insurance covers most remaining out-of-pocket expenses such as copays and deductibles.

France is known for spending significantly less per capita than the United States. Cost controls come from nationally negotiated fee schedules and drug pricing rather than limits on access.

What’s striking is that in 2019, US healthcare spending reached $11,072 per person—over double the average of $5,505 across wealthy European nations. Yet despite spending roughly twice as much per person, American health outcomes often lag behind.

The Outcomes Question

This is where the comparison gets uncomfortable for American exceptionalism. The U.S. has the lowest life expectancy at birth among comparable wealthy nations, the highest death rates for avoidable or treatable conditions, and the highest maternal and infant mortality.

In 2023, life expectancy in comparable countries was 82.5 years, which is 4.1 years longer than in the U.S. Japan manages this with healthcare spending at just $5,300 per capita, while Americans spend more than double that amount.

Now, it’s important to note that healthcare systems don’t operate in a vacuum. Life expectancy is influenced by many factors beyond medical care—diet, exercise, smoking, gun violence, drug overdoses, and social determinants of health all play roles. But when you’re spending twice as much and getting worse results, it suggests the system itself might be part of the problem.

Advantages of Single-Payer Systems

The case for single-payer rests on several compelling points. First, administrative simplicity translates to real cost savings. A study found that the administrative burden of health care in the United States was 27 percent of all national health expenditures, with the excess administrative cost of the private insurer system estimated at about $471 billion in 2012 compared to a single-payer system like Canada’s. That’s over $1 out of every $5 of total healthcare spending just going to paperwork, billing disputes, and insurance company profit and overhead before any patient receives care.

Universal coverage is another major advantage. In a properly functioning single-payer system, nobody goes bankrupt from medical bills, nobody delays care because they can’t afford it, and nobody loses coverage when they lose their job. The peace of mind that comes with knowing you’re covered regardless of employment status or pre-existing conditions is difficult to quantify but enormously valuable.

Single-payer systems also have significant negotiating power. When one entity is buying drugs and services for an entire nation, pharmaceutical companies and medical device manufacturers have much less leverage to charge whatever they want. This helps explain why prescription drug prices in other countries are often a fraction of prices in the U.S.

Disadvantages and Trade-offs

The critics of single-payer systems aren’t wrong about everything. Wait times are a genuine concern in some systems. When prices and overall budgets are tightly controlled, some countries experience longer waits for selected elective surgeries, imaging, or specialty visits, especially if investment lags demand.

In 2024, Canadian patients experienced a median wait time of 30 weeks between specialty referral and first treatment, up from 27.2 weeks in 2023, with rural areas facing even longer delays. For procedures like elective orthopedic surgery, patients wait an average of 39 weeks in Canada.

However, it’s crucial to understand that wait times are not a result of the single-payer system itself but of system management, as wait times vary significantly across different single-payer and social insurance systems. Many European countries with universal coverage don’t experience the same wait time issues that plague Canada.

The transition costs are also substantial. Moving from our current system to single-payer would disrupt a massive industry. Over fifteen percent of our economy is related to health care, with half spent by the private sector. Around 160 million Americans currently have insurance through their employers, and transitioning all of them to a government-run plan would be an enormous administrative and political challenge.

A large national payer can be slower to change benefit designs or adopt new payment models; shifting political majorities can affect funding levels and benefit generosity.

Taxes would need to increase significantly to fund such a system, though proponents argue this would be offset by the elimination of insurance premiums, deductibles, and co-pays. It’s essentially a question of whether you’d rather pay through taxes or through premiums—the money has to come from somewhere.

Advantages of America’s Mixed System

Our current system does have some genuine strengths. Innovation thrives in the American healthcare market. The profit motive, for all its flaws, does drive pharmaceutical research and medical device development. American medical schools and research institutions lead the world in many areas of medicine. Academic medical centers and specialty hospitals deliver advanced procedures and complex care that attract patients internationally.

The system also offers more choice for those who can afford it. If you have good insurance, you typically face shorter wait times for elective procedures and can often see specialists without lengthy delays. Americans with high-quality employer-sponsored coverage give their plans relatively high ratings.

Competition between providers can theoretically drive quality improvements, though this effect is often undermined by the complexity of the market and the difficulty consumers face in shopping for healthcare.

Disadvantages of the Current U.S. System

The most glaring problem is simple: The United States remains the only developed country without universal healthcare, and 30 million Americans remain uninsured despite gains under the Affordable Care Act, and many of these gains will soon be lost. Being uninsured in America isn’t just an inconvenience—it can be deadly. People delay care, skip medications, and avoid preventive screenings because of cost concerns.

The administrative complexity is staggering. Doctors spend enormous amounts of time dealing with insurance companies, prior authorizations, and billing disputes. Hospitals employ armies of billing specialists just to navigate the maze of different insurance plans, each with its own rules, formularies, and coverage determinations. U.S. administrative costs account for ~25% of all healthcare spending, among the highest in the world.

Medical bankruptcy is uniquely American. Even people with insurance can find themselves financially devastated by serious illness. High deductibles, surprise bills, and out-of-network charges create a minefield of potential financial catastrophe. Studies of U.S. bankruptcy filings over the past two decades have consistently found that medical bills and medical problems are a major factor in a large share of consumer bankruptcies. Recent summaries suggest that roughly two‑thirds of US personal bankruptcies involve medical expenses or illness-related income loss, and around 17% of adults with health care debt report declaring bankruptcy or losing a home because of that debt.

The system is also profoundly inequitable. Quality of care often depends more on your job, your income, and your zip code than on your medical needs. Out-of-pocket costs per capita have increased as compared to previous decades and the burden falls disproportionately on those least able to afford it.

What Europe Shows Us

The European experience demonstrates that there isn’t one “right” way to achieve universal coverage. The UK’s NHS, Germany’s sickness funds, and France’s hybrid system all manage to cover everyone at roughly half the per-capita cost of American healthcare. Universal Health Coverage exists in all European countries, with healthcare financing almost universally government managed, either directly through taxation or semi-directly through mandated and government-subsidized social health insurance.

They’ve accomplished this through various combinations of centralized negotiation of drug prices, global budgets for hospitals, strong primary care systems that serve as gatekeepers to more expensive specialist care, emphasis on preventive services, and regulation that prevents insurance companies from cherry-picking healthy patients.

Are these systems perfect? No. One of the major disadvantages of centralized healthcare systems is long wait lists to access non-urgent care, though Americans often wait as long or longer for routine primary care appointments as do patients in most universal-coverage countries. Many European countries are wrestling with funding challenges as populations age and expensive new treatments become available. But they’ve solved the fundamental problem that America hasn’t: they ensure everyone has access to healthcare without the risk of financial ruin.

The Path Forward?

The debate over healthcare in America often presents false choices. We don’t have to choose between Canadian-style single-payer and our current system—there are multiple models we could adapt. We could move toward a German-style system with heavily regulated non-profit insurers. We could create a robust public option that competes with private insurance. We could expand Medicare gradually by lowering the eligibility age over time.

What’s clear from international comparisons is that the status quo is unusually expensive and produces mediocre results. We’re paying premium prices for economy outcomes. Whether single-payer is the answer depends partly on your priorities. Do you value universal coverage and cost control more than unlimited choice? Are you willing to accept potentially longer wait times for non-urgent care in exchange for lower costs and universal access? How much do you trust government to manage a program this large?

These aren’t easy questions, and reasonable people disagree. But the evidence from Europe suggests that universal coverage at reasonable cost is achievable—it just requires us to make some choices about what we value most in a healthcare system.

Sources:

Centers for Medicare & Medicaid Services National Health Expenditure Data: https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical
Commonwealth Fund international comparisons: https://www.commonwealthfund.org/publications/issue-briefs/2023/jan/us-health-care-global-perspective-2022
Peterson-KFF Health System Tracker: https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy-compare-countries/
Wikipedia overview of single-payer systems: https://en.wikipedia.org/wiki/Single-payer_healthcare
Harvard Health discussion of single-payer: https://www.health.harvard.edu/blog/single-payer-healthcare-pluses-minuses-means-201606279835
BMC study on administrative costs: Referenced in Wikipedia article on single-payer healthcare
Fraser Institute wait times data: https://www.fraserinstitute.org/studies/waiting-your-turn-wait-times-for-health-care-in-canada-2024
Healthcare systems comparison (European models): https://www.healthcare-now.org/euhealthcare/

Understanding Parkinson’s Disease: From Diagnosis to Daily Living

By John Turley

On December 13, 2025

In Medicine, Uncategorized

When most people think of Parkinson’s disease, they picture the characteristic tremor—that involuntary shaking that has become almost synonymous with the condition. But the reality is far more complex than just one visible symptom. Let’s dig into what’s actually happening in the brain, how doctors figure out what’s going on, and what living with this condition really looks like.

What Causes Parkinson’s Disease?

Here’s where things get frustrating for researchers: despite decades of study, scientists still don’t know exactly what causes the nerve cells in the brain to die. I’m going to apologize in advance because I’m going to be using a lot of “doctor talk”—no way around it.

What we do know is that nerve cells (neurons) in the substantia nigra portion of the basal ganglia—an area of the brain controlling movement—become impaired or die, and these neurons normally produce dopamine, an important brain chemical. When these cells stop working properly, dopamine levels drop, and that’s when movement problems begin showing up.

But dopamine isn’t the whole story. People with Parkinson’s also lose nerve endings that produce norepinephrine, the main chemical messenger of the sympathetic nervous system, which helps explain why the disease affects so much more than just movement—things like blood pressure, digestion, and energy levels all take a hit.

Most Parkinson’s cases are idiopathic, meaning the cause is unknown, though contributing factors have been identified. Current thinking suggests a complicated mix of genetic and environmental factors. About 5% to 10% of cases begin before age 50, and these early-onset forms are often, though not always, inherited.

Some risk factors have emerged from research: age is the most significant, with about 1% of those over 65 and around 4.3% of those over 85 affected. Traumatic brain injury significantly increases risk, especially if recent, and repeated head injuries from contact sports can cause what’s called post-traumatic parkinsonism. Muhammad Ali is a classic example of this.

Exposure to pesticides and industrial chemicals has also been identified as a risk factor. Interestingly, large epidemiologic studies consistently show that people who smoke have a lower risk of being diagnosed with Parkinson’s disease than never‑smokers, although smoking is still strongly discouraged because of its many harmful health risks. Large cohort studies in the U.S. and Europe generally find no direct association between alcohol consumption and Parkinson’s disease. A few observational studies show that moderate drinkers have slightly lower Parkinson’s rates. However, researchers believe this may be due to reverse causation (people in early or undiagnosed stages often reduce drinking because of GI or mood changes) and lifestyle confounders (moderate drinkers may differ in socioeconomic status, diet, or activity level). So, the “protective” effect is considered speculative, not causal.

The Symptoms: More Than Just Shaking

The hallmark movement symptoms—what doctors call “motor symptoms”—are what usually bring people to the doctor. Slowed movements, called bradykinesia, is required for a Parkinson’s diagnosis. People describe it as muscle weakness, though it’s really about control, not strength. The classic tremor, stiffness, and balance problems round out the main movement issues. Patients frequently show reduced arm swing, shuffling gait, difficulty initiating movement or turning, masked facial expression, decreased blinking, and soft or monotone speech.

But here’s what often surprises people: many individuals later diagnosed with Parkinson’s notice that prior to experiencing stiffness and tremor, they had sleep problems, constipation, loss of smell, and restless legs. These “prodromal symptoms” can show up years before the movement problems become obvious. Other early signs include mood disorders like anxiety and depression.

The cognitive side deserves attention too. Some people experience changes in cognitive function, including problems with memory, attention, and the ability to plan and accomplish tasks, though hard to pin down due to concurrence with age related memory problems, 20% at the time of diagnosis is a commonly cited number. More contested is how many develop Parkinson’s dementia, with estimates ranging from 20% all the way to 85%.

How Doctors Make the Diagnosis

Here’s something that might surprise you: there are currently no blood or laboratory tests to diagnose non-genetic cases of Parkinson’s. The standard diagnosis is clinical, meaning there’s no test that can give a conclusive result—certain physical symptoms need to be present.

Doctors typically diagnose Parkinson’s by taking a detailed medical history and performing a neurological examination. If symptoms improve after starting medication, that’s another indicator that the person has Parkinson’s.

There are some imaging tools available. The FDA approved an imaging scan called the DaTscan in 2011, which allows doctors to see detailed pictures of the brain’s dopamine system using a radioactive drug and SPECT scanner. But this scan can’t definitively diagnose Parkinson’s though it helps rule out conditions that mimic it. A hallmark of Parkinson’s is the buildup of misfolded alpha-synuclein proteins (Lewy bodies) inside neurons. Whether this is a cause, an effect, or both is still under study—this part of the science remains somewhat speculative.

Recently, researchers developed something more promising: the alpha-synuclein seeding amplification assay can detect abnormal alpha-synuclein in spinal fluid and may detect Parkinson’s in people who haven’t been diagnosed yet. The catch? It requires a spinal tap and isn’t widely available, though scientists are working on blood and saliva tests.

The early diagnostic challenge is real. Many disorders can cause similar symptoms, and people with Parkinson’s-like symptoms from other causes are sometimes said to have parkinsonism, which includes conditions like multiple system atrophy and Lewy body dementia that require different treatments.

What to Expect: The Prognosis

Let’s address the big question: how does Parkinson’s affect life expectancy? The news here is better than you might think. The average life expectancy of a person with Parkinson’s is generally the same as for someone without the disease.

More specifically, average life expectancy has increased by about 55% since 1967, rising to more than 14.5 years from diagnosis. Modern treatments have made a huge difference. Research indicates that those with Parkinson’s and normal cognitive function appear to have a largely normal life expectancy.

That said, timing matters. Research from 2020 suggests that people who receive a diagnosis before age 70 usually experience a greater reduction in life expectancy, and males with Parkinson’s may have a greater reduction in life expectancy than females.

The disease is progressive, meaning it gets worse over time, but symptoms and progression vary from person to person, and neither you nor your doctor can predict which symptoms you’ll get, when, or how severe they’ll be. The tremor-dominant type usually has a more favorable prognosis than the hypokinetic type.

What actually causes death in advanced Parkinson’s? Advanced symptoms can cause falls, pressure ulcers, swallowing difficulties and general frailty, all of which are linked to death. Aspiration pneumonia—when you inhale food or liquid into the lungs—is the leading cause of death for people with Parkinson’s.

Managing the Disease

Currently, there’s no cure for Parkinson’s, but medications or surgery can improve many of the movement symptoms.

The gold standard medication is levodopa (often combined with carbidopa as Sinemet). Healthcare providers use levodopa cautiously and they commonly combine it with other medications to keep your body from processing it before it enters your brain. This helps avoid side effects like nausea, vomiting, and low blood pressure when standing up. The tricky part? Over time, the way your body uses levodopa changes, and it can lose effectiveness.

Beyond levodopa, doctors use MAO-B inhibitors and dopamine agonists. As the disease progresses, these medications become less effective and may cause involuntary muscle movements. When drugs stop working well, there are surgical options to treat severe motor symptoms.

The main surgical treatment today is called deep brain stimulation (DBS). It is the most important therapeutic advancement since the development of levodopa, and it’s been FDA-approved since the late 1990s A surgeon places thin metal wires called electrodes into one or both sides of the brain, in specific areas that control movement. A second procedure implants an impulse generator battery under the collarbone or in the abdomen. It is similar to a heart pacemaker and about the size of a stopwatch, this device delivers electrical stimulation to those targeted brain areas.

A new treatment that is being used is focused ultrasound. Guided by MRI, high-intensity, inaudible sound waves are emitted into the brain, and where these waves cross, they create high energy that destroys a very specific area connected to tremor. It’s considered non-invasive and the FDA has approved it for Parkinson’s tremor that doesn’t respond to medications.

Don’t underestimate lifestyle interventions either. Physical therapy can improve balance and address muscle stiffness, and regular exercise improves strength, flexibility, and balance. Eating a balanced diet helps—drinking plenty of water and eating enough fiber reduces constipation, while omega-3 fats and magnesium may boost cognition and help with anxiety.

Parkinson’s disease sits at the intersection of aging, genetics, environment, and biology. Diagnosis is clinical, progression is gradual and variable, and treatment has become increasingly sophisticated. While it remains incurable, early diagnosis, personalized medication plans, targeted therapies like DBS, and consistent exercise allow many people to maintain meaningful independence for years.

The key message from specialists? Treatment makes a major difference in keeping symptoms from having worse effects, and adjustments to medications and dosages can hugely impact how Parkinson’s affects your life.